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I. SUMMARY 
Introduction:	 This health consultation was conducted because a resident of the 
community of Winchester, Massachusetts, and the Winchester Board of 
Health was concerned about suspected increases of childhood cancer and 
potential health risks related to surface soil at Ginn Field (as well as 
surface water and sediment contamination of the section of the Aberjona 
River that abuts the field). 
Overview:	 The MDPH has reached several important conclusions about the incidence 
of childhood cancer in Winchester and potential environmental exposures 
at Ginn Field. 
Conclusion 1:	 The MDPH concluded that accidentally eating or touching soil at Ginn 
Field is not expected to harm people’s health.   
Basis for Decision:	 Past activities at the Industri-Plex and Wells G & H Superfund sites in 
Woburn, MA resulted in chemical contaminants in the surface water and
sediment of the Aberjona River.  Based on soil sampling conducted 
directly downstream of Ginn Field, surface soil on or near the field is 
likely impacted by contamination deposited by flood waters of the 
abutting Aberjona River. As a result, adults, adolescents, and younger 
children could come into contact with chemical contaminants while 
playing sports at or visiting the field either in the past or presently.  Based 
on available information and conservative assumptions about the 
frequency and duration of potential exposures, levels of chemical 
contaminants that could get into a child’s or an adult’s body are below 
levels that would harm their health.   
Because the maximum concentration of lead in surface soil was above 
health-based comparison values and children may have been exposed 
while playing at Ginn Field, the MDPH evaluated data on blood lead 
levels among children who resided in Winchester between July 1999 and 
June 2010. No unusual concentration of children with elevated blood lead 
levels was noted in areas proximate to the field.  In addition, the MDPH 
used the USEPA Integrated Exposure Uptake Biokinetic (IEUBK) model 
to predict blood lead levels based on lead intake via various sources.  
Using conservative assumptions, this model predicted that about 0.6% of a 
hypothetical population of children under the age of 7 years who 
trespass/play on the site would have blood lead levels greater than 10 
µg/dl, which the Centers for Disease Control and Prevention (CDC) define 
as a level of concern. The prediction of less than a 1% risk of blood lead 
levels above 10 µg/dl is below the USEPA Office of Solid Waste and 
Emergency Response’s specified level of protectiveness of no more than a 
5% risk of an elevated blood lead level for a given scenario.  Based upon 
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this information, children who played or visited Ginn Field are unlikely to 
have experienced elevated blood lead levels as a result of potential 
exposure to lead in surface soil at the site.  
In the future, deposition of contaminants from flood waters onto the 
surface soil at Ginn Field is expected to be minimal after the channel in 
this section of the Aberjona River is deepened as part of a series of flood 
mitigation projects that are currently underway.  Therefore, exposure of 
adults, adolescents or children to contaminants in surface soil deposited by
flood waters was eliminated as an exposure pathway in the future.   
Conclusion 2:	 The MDPH concluded that accidentally eating or touching sediment while 
playing or wading in the Aberjona River near Ginn Field is not expected 
to harm people’s health.  
Basis for Decision: 	 Based on available sampling data, sediment in the section of the Aberjona 
River directly adjacent to Ginn Field contains chemical contaminants.  
Adults, adolescents, and younger children could come into contact with 
contaminants in the sediment while wading or playing in the section of the 
Aberjona River that abuts Ginn Field in the past or present.  Based on 
conservative assumptions about the frequency and duration of potential 
exposures, levels of chemical contaminants that could get into a child’s or 
an adult’s body are below levels that would harm their health.  Likewise, 
future exposures to constituents in sediment are unlikely to cause health 
concerns given that there are no known ongoing sources and, hence, 
similar or lower concentrations are expected in the future.    
Conclusion 3:	 The MDPH concluded that accidentally drinking or touching surface water 
while playing or wading in the Aberjona River near Ginn Field is not 
expected to harm people’s health.   
Basis for Decision:	 Sampling conducted directly upstream of Ginn Field demonstrates that 
surface water in the stretch of the Aberjona River adjacent to the field 
contains chemical contaminants. Adults, adolescents, and younger 
children could come into contact with contaminants while wading or 
playing in the section of the Aberjona River that abuts Ginn Field in the 
past, present and future. Based on available information and conservative 
assumptions about the frequency and duration of potential exposures, 
levels of chemical contaminants that could get into a child’s or an adult’s 
body during either base flow or storm flow conditions are below levels 
that would harm their health.   
Conclusion 4:	 The MDPH concluded that tap water in the community of Winchester is 
not impacted by contaminants related to the Aberjona River and, therefore, 
is not expected to harm people’s health.   
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Basis for Decision:	 Groundwater in the community of Winchester is not used as a source of 
drinking water. The drinking water for the community of Winchester is 
supplied by local reservoirs and the Massachusetts Water Resources 
Authority. Therefore, exposure of individuals to contaminants in 
groundwater was eliminated as a pathway.   
Conclusion 5:	 The MDPH concluded that accidentally touching pesticides that were
sprayed in the past at Ginn Field is not expected to harm people’s health.  
No pesticides have been applied to Ginn Field since 2005.   
Basis for Decision:	 Based on the restricted frequency of use as well as the toxicological 
characteristics and carcinogenicity of the active ingredients of the 
pesticides used at Ginn Field, post-application exposure of children or 
adults is not expected to harm their health.   
Due to the possible association between 2,4-D and non-Hodgkin’s 
lymphoma (NHL), the MDPH reviewed the incidence of NHL among 
adults and children in the community of Winchester during the time period 
2000-2005. During this six-year time period, the number of observed 
diagnoses was slightly greater than expected but not statistically 
significant. No unusual spatial or temporal trends were observed.   
Conclusion 6:	 The MDPH concluded that the incidence of childhood cancer was slightly 
elevated in the community of Winchester during the 6-year time period 
2000-2005 but was not statistically significant.  The incidence among 
females was slightly less than expected, whereas, among males, it was 
more than expected but the difference was not statistically significant.  A
qualitative review of childhood cancer in Winchester for 2006-2008 was 
also conducted. No unusual trends emerged when the overall age, gender 
and histology patterns were examined in more detail for the time period 
2000-2008. 
Basis for Decision:	 To determine whether the incidence of childhood cancer in Winchester 
was elevated, the observed number of cancer diagnoses in the community 
was compared to the number that would be expected based on the 
statewide cancer rate. Between 2000 and 2005, 7 diagnoses were reported 
when approximately 6 would be expected.  This difference was not 
statistically significant. The incidence among females was slightly less 
than expected (1 observed compared to about 3 expected), whereas, 
among males, it was more than expected (6 observed compared to about 3 
expected) but not statistically significant.  During this time period, the 
following four types of cancer were diagnosed among children in 
Winchester: CNS tumors, leukemia, neuroblastoma, and malignant 
gonadal germ cell tumors.   
3
 
  
 
 
 
________________________________________________________________________ 
 
________________________________________________________________________ 
 
 
A qualitative review of childhood cancer in Winchester for more recent 
years was also conducted. Between 2006 and 2008, six other children in 
Winchester were diagnosed with the following five types of cancer: 
leukemia, malignant gonadal germ cell tumors, cancer of the bone, soft 
tissue sarcoma, and an unspecified carcinoma.   
Overall, the distribution of cancer types diagnosed among children in 
Winchester during 2000-2008 was generally consistent with state and 
national trends. Furthermore, analysis of the geographic distribution of 
place of residence for children diagnosed with cancer in Winchester 
during 2000-2008 did not reveal any atypical spatial patterns.  Although 
some diagnoses during 2006-2008 occurred among children whose 
residences at the time of diagnosis were in relative close proximity to one 
another, the overall geographic distribution was generally consistent with 
population density. 
Next Steps:	  The MDPH recommends no further investigation of childhood cancer 
incidence in Winchester at this time.    
For More Information:	 If you have concerns about your health, you should contact your 
health care provider. You may also call the MDPH at 617-624­
5757 and ask for information on the Ginn Field site.   
For more information about pesticides, contact the National 
Pesticide Information Center at 1-800-858-7378 or the Pesticide 
Program at the Massachusetts Department of Agricultural 
Resources at (617) 626-1776. 
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II. INTRODUCTION 
At the request of a concerned resident and the Winchester Board of Health (BOH), the 
Community Assessment Program (CAP) of the Massachusetts Department of Public 
Health (MDPH), Bureau of Environmental Health (BEH), reviewed the incidence of 
childhood cancer (i.e., ages 0-19) for the community of Winchester and conducted an 
evaluation of potential environmental exposures related to Ginn Field1. Concerns 
focused on possible health risks from exposure to contaminants in the surface water and 
sediment of the Aberjona River, which abuts the athletic field and floods periodically.   
This Health Consultation (HC) provides both quantitative and qualitative evaluations of 
childhood cancer (all types) for all children living in Winchester who were diagnosed 
between 2000–2008 to determine if childhood cancer may be occurring in an unusual 
pattern in the community.  This investigation also provides a review of potential 
pathways of exposure to contaminants detected in surface soil near Ginn Field as well as 
surface water and sediment in the stretch of the Aberjona River adjacent to the field.   
Additionally, a review of pesticides used at Ginn Field was conducted.   
III. BACKGROUND 
The community of Winchester is located 8 miles northwest of Boston in Middlesex 
County. Ginn Field, which is managed by the Winchester Department of Public Works 
(DPW), encompasses 5 acres and is located on Bacon Street, off of Mystic Valley 
Parkway, in southeastern Winchester (Figure 1).  To the east, Ginn Field directly abuts
the Aberjona River, which is a small stream approximately 15 to 20 feet wide in this 
stretch, and a narrow strip of woods.  Farther east, residential properties are located on 
Mystic Valley Parkway. Across Bacon Street to the south is the Wedgemere MBTA 
station and wooded wetlands. Farther south is the inlet to Upper Mystic Lake.  The 
western edge of Ginn Field abuts the MBTA commuter rail line.  Farther west, residential 
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properties are located on Ginn Road. To the north, the field is bordered by a parking area 
and the Aberjona River with residential properties nearby.   
Two sites that are listed on the National Priorities List for Uncontrolled Hazardous Waste 
Sites (also referred to as Superfund sites) by the U.S. Environmental Protection Agency 
(USEPA) are located north of Ginn Field in the community of Woburn and are 
hydraulically connected by the Aberjona River.  The Industri-Plex Superfund site 
encompasses 245 acres and is located approximately one mile north of the Wells G & H 
Superfund site, which itself encompasses 330 acres and is located about 3.5 miles north 
of Ginn Field (Figure 2). Wells G & H were two municipal wells developed in 1964 and 
1967 to supplement the water supply for the City of Woburn.  Both wells were shut down 
in 1979 after contamination was detected.  Five separate properties were found to be 
contributing sources of contamination to the aquifer that supplied water to these two 
wells. Groundwater was contaminated with volatile organic compounds (VOCs) and 
soils were contaminated with polycyclic aromatic hydrocarbons (PAHs), polychlorinated 
biphenyls (PCBs), VOCs and pesticides.  The Industri-Plex Superfund site was a former 
chemical and glue manufacturing facility for over 100 years until it was developed for 
industrial use during the 1970s.  The manufacturing by-products and wastes contaminated 
the groundwater with VOCs as well as ammonia and metals such as arsenic.  Soils were 
contaminated with heavy metals, including arsenic, chromium, and lead.  The Aberjona 
River flows through both of these Superfund sites and continues south approximately six 
river miles before discharging to the Mystic Lakes in Winchester (Tetra Tech 2005; 
USEPA 2005a, 2009a, 2009b). Just before discharging to Upper Mystic Lake, it passes 
Ginn Field, which is located at an elevation lower than that of the surrounding streets, 
houses and rail line, and, as a result, is subject to periodic flooding.  At such times, 
surface water and sediment of the Aberjona River may be transported by flood waters and 
deposited on the surface soil at Ginn Field.   
In 2002, the USEPA combined the separate surface water and sediment investigations
that were being performed at the two Superfund sites into one study called the Multiple 
Source Groundwater Response Plan (MSGRP) Remedial Investigation to more efficiently 
evaluate contamination and assess potential risk for the entire Aberjona River.  As part of 
  
 
the MSGRP Remedial Investigation, a baseline risk assessment was conducted.  The 
findings were used to formulate a comprehensive strategy to address human health and 
ecological risks. Remediation activities at the Superfund sites, which are still on-going, 
have included removing contaminated soils, placing a protective cap over more than 100 
acres of contaminated soils, dredging and disposing of contaminated sediment, and 
treating groundwater from a contaminated aquifer.  While remediation efforts have been 
proceeding, significant portions of the sites have been redeveloped.  The sites are 
currently occupied by numerous retail, commercial, and industrial businesses as well as 
the Anderson Regional Transportation Center, a 33-acre commuter transportation hub, 
which was constructed in the late 1990s and opened in May 2001 (Tetra Tech 2005; 
USEPA 2009a,b). 
IV.	  EVALUATION OF POTENTIAL COMMUNITY EXPOSURE 
PATHWAYS AND HEALTH CONCERNS 
An evaluation of potential pathways of exposure was conducted to determine whether 
contaminants in the stretch of the Aberjona River adjacent to Ginn Field or pesticides 
applied to the field could impact children playing at the field in the past, present, or
future. In general, five conditions must be present for exposure to occur.  First, there 
must be a source of the chemical.  Second, an environmental medium must be 
contaminated by either the source or by chemicals transported away from the source.  
Third, there must be a location where a person can potentially contact the contaminated 
medium.  Fourth, there must be a means by which the contaminated medium could enter 
a person’s body, such as ingestion, inhalation, or dermal absorption.  Finally, a 
population of individuals that could potentially be exposed must be present (ATSDR 
2005). A completed exposure pathway exists when all five elements are present and 
indicates that exposure to humans occurred in the past, is occurring in the present, or will 
occur in the future. A potential exposure pathway exists when one or more of the five 
elements is either missing or uncertain and indicates that exposure to a contaminant could 
have occurred in the past, could be occurring in the present, or could occur in the future.  
An exposure pathway can be eliminated if at least one of the five elements is missing and 
will not likely be present in the future.  
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In order to evaluate concerns about potential environmental exposures to contaminants 
from the section of the Aberjona River that abuts Ginn Field and contaminants possibly 
deposited by flood waters, the MDPH contacted the USEPA to obtain and review 
comprehensive and up-to-date environmental information related to the Wells G & H and 
Industri-Plex Superfund sites. For the purposes of the MSGRP Remedial Investigation, 
the USEPA divided a six-mile stretch of the Aberjona River into seven reaches that 
extend from the town line between Wilmington and Woburn to the Upper and Lower 
Mystic Lakes in Arlington.  The section of the Aberjona River that borders Ginn Field in 
Winchester is located within Reach 5, which extends from the Mill Pond outlet south to 
the Upper Mystic Lake inlet (Figure 3).  Sampling data available for this reach include 
soil, sediment, and surface water samples (Tetra Tech 2005).  Additional sediment data 
specific to the section of the Aberjona River immediately adjacent to Ginn Field were 
available from sampling efforts related to a series of flood mitigation projects that are 
currently underway (AECOM 2010). 
The USEPA concluded in the MSGRP Remedial Investigation that heavy metals are the 
principal contaminants of concern in surface water and sediment throughout the entire 
study area, with arsenic representing the most significant metal present at elevated 
concentrations throughout the system. The principal source of contamination is the soils 
underlying the Industri-Plex Superfund site that are impacting groundwater, which in turn 
discharges to surface water.  Organic compounds originating from the Industri-Plex site 
were shown to attenuate within the first reach of the Aberjona River whereas metals were 
shown to migrate farther downstream through dissolved phases and sediment transport 
mechanisms during both base flow and storm flow conditions.  It was determined that the 
impacted media in Reach 5 consist of sediment and surface water with metals as the 
contaminants of concern.  Specifically, arsenic, iron and lead were the surface soil and
sediment contaminants determined to exceed USEPA Region 9 Preliminary Remediation 
Goals, which were used by the USEPA as comparison values (Tetra Tech 2005).  Based 
on this information, the MDPH conducted its evaluation with a focus on these three metal 
contaminants in this HC.   
8
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The maximum concentrations of contaminants detected in the various types of 
environmental media were identified and compared to health-based comparison values 
(ATSDR 2005, 2010a, 2010b; USEPA 2010; MDEP 2010).  Comparison values are 
developed based on health guidelines and assumed situations that represent conservative 
estimates of human exposure.  Contaminant concentrations detected in environmental 
media that are less than a comparison value are not likely to pose a health threat.  
However, contaminant concentrations detected in environmental media above a 
comparison value do not necessarily indicate that a health threat is present.  In order for a 
compound to impact one’s health, it must not only be present in the environmental media, 
but one must also come in contact with it.  Therefore, if a contaminant concentration is
greater than the comparison value, the potential for exposure should be further evaluated 
(ATSDR 2005). Concentration levels that are considered typical or “background” were 
also used in the analysis (USGS 1984; MDEP 2002).  In addition, essential nutrients for 
which comparison values were not available were not retained for further analysis 
(ATSDR 2005, USEPA 1989). 
In order to evaluate concerns about potential exposure to pesticides applied on Ginn 
Field, the MDPH contacted the Winchester DPW to obtain available information 
regarding current and historical applications.  The chemical ingredients of each pesticide 
were identified from their Material Safety Data Sheets (MSDS).  Information about the 
toxicity and carcinogenicity of each active ingredient was obtained from a variety of 
sources, including the International Agency for Research on Cancer (IARC) and the 
USEPA Office of Pesticide Programs.     
A. Exposure to Soil 
In Reach 5, surface soil samples (0 to 6 inches) were collected by the USEPA in 2004 
from nine locations along the bank of a ponded area of the Aberjona River south of 
Bacon Street, downstream of Ginn Field. The purpose of collecting these samples was to 
investigate potential metals contamination deposited by flood waters.  Levels of arsenic 
and lead in at least one sample exceeded both soil comparison values and typical 
background values (Tetra Tech 2005; ATSDR 2010a; USEPA 2010).  The maximum 
concentration of iron (34,000 ppm) detected did not exceed the applicable soil 
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comparison value.  Although the maximum concentration of chromium (90 ppm)
detected exceeded the soil comparison value for children, it is within the range of typical 
background values and, therefore, further analysis was not conducted.  A summary of the 
maximum and average concentration of contaminants detected in surface soil samples
that exceeded comparison values is presented in Table 1.   
Because Ginn Field is located in a low-lying area subject to flooding, contaminants in the 
surface water and sediment of the Aberjona River may periodically be transported by 
flood waters and deposited on the surface soil at Ginn Field.  As a result, it is possible 
that children participating in sports, adult spectators, and others visiting Ginn Field may 
have experienced exposure opportunities to arsenic and lead via incidental ingestion of or 
dermal contact with contaminated floodplain soils at Ginn Field either in the past or 
presently. In order to evaluate the potential for carcinogenic health effects, exposure 
doses were estimated and compared to health guideline values for cancer.  It should be 
noted that exposure to subsurface soil is not expected due to its depth below ground 
surface and, therefore, was not evaluated.   
The USEPA and the IARC have classified inorganic arsenic as a known carcinogen based 
on sufficient evidence in humans.  Several studies have shown that ingestion of inorganic 
arsenic can increase the risk of skin cancer and cancer in the liver, bladder, and lungs.  
The degree of risk depends on the intensity and frequency of exposure.  It is of note that 
the majority of the data on the effects of exposure of humans to arsenic has focused on 
adults, with few studies specific to children.  Also, data linking inorganic arsenic to 
cancer or noncancer health effects are primarily from studies evaluating daily exposure to 
inorganic arsenic in drinking water over many years.  Furthermore, dermal uptake of 
inorganic arsenic is considered to be sufficiently limited such that other routes of 
exposure, such as ingestion, are almost always expected to be of greater concern 
(ATSDR 2007a). 
Under the conservative assumption that adults (ages 18 and above), adolescents (ages 12 
through 17) and younger children (under age 11) incidentally ingested surface soil with 
the maximum concentration of arsenic that was detected in Reach 5 (98 mg/kg) for 5 
days/week for 22 weeks per year during the warmer months of the year (from May 
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through September) for either 11 years for the child, 17 years for the adolescent or 30 
years for the adult, the estimated exposure would not result in an unusual cancer risk.  
Also, the estimated exposure level would be below the ATSDR Minimal Risk Level 
(MRL). The MRL is an estimate of daily exposure to a contaminant below which 
adverse noncancer health outcomes are unlikely to occur.  Since the estimated exposure 
doses for adults, adolescents and younger children are below the MRL, noncancer health 
effects would not be expected.  Under the same exposure conditions and assumptions 
described above, dermal exposure to the maximum concentration of arsenic detected in 
surface soil samples is also not expected to result in an unusual cancer risk or adverse 
noncancer health effects in adults, adolescents or younger children.  See Appendices A
and B for more information on the exposure dose and cancer risk calculations.  It should 
be noted that the analysis provided here examines metals deposited by flood waters as 
represented by the ponded area located south of Bacon Street, downstream of Ginn Field.   
In humans, the main target for lead toxicity is the nervous system.  Lead exposure is of 
most concern for children six years of age or younger because they absorb more lead than 
older children or adults, have more hand to mouth activity that results in greater 
incidental ingestion of soil, and are more susceptible to health effects from lead exposure.  
In order to evaluate potential health concerns related to exposure opportunities to lead in 
surface soil at Ginn Field, the MDPH used the USEPA Integrated Exposure Uptake 
Biokinetic (IEUBK) Model for Lead in Children (USEPA 2007).  This model is widely 
used throughout the country to predict blood lead levels based on lead intake via various 
sources (e.g., soil, food, water). Environmental data specific to a given scenario are input 
into the model in order to predict blood lead levels for young children (aged 6 months to 
7 years). The model generally uses typical or average concentrations in the various 
source media, assumes daily exposures, and predicts blood lead concentrations based on 
chronic exposures (e.g., 1 year or more).   
To be conservative, the MDPH used the IEUBK model with the assumptions that young 
children visited the site 5 days each week for 22 weeks of the year for 7 years, that the 
average lead concentration detected in surface soil (298 mg/kg) within Reach 5 reflects 
the range of contaminant concentrations that would likely have been ingested over time, 
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and that half of a child’s typical daily incidental soil ingestion occurred during the time 
spent on the site. Using these assumptions, the predicted mean blood lead concentration 
was 3.1 micrograms per deciliter (μg/dL). The IEUBK model predicted that about 0.6% 
of this hypothetical population of children under the age of 7 years who trespass/play on 
the site would have blood lead levels greater than 10 μg/dL, which the Centers for 
Disease Control and Prevention (CDC) define as a level of concern (ATSDR 2007b).  
The prediction of less than a 1% risk of blood lead levels above 10 μg/dL is below the 
USEPA Office of Solid Waste and Emergency Response’s specified level of 
protectiveness of no more than a 5% risk of an elevated blood lead level for a given 
scenario (USEPA 2007). Thus, it appears unlikely that young children 
trespassing/playing at Ginn Field would have blood lead levels above the current CDC 
level of concern given exposure opportunities at the site.  In addition, it should be noted 
that the average concentration of lead detected in surface soil is within the range of 
typical background values. 
To further address concerns of past exposure to lead in surface soil at Ginn Field, the 
MDPH evaluated readily available data on blood lead levels among children living in 
Winchester.  Data were obtained from the MDPH BEH Childhood Lead Poisoning 
Prevention Program (CLPPP). CLPPP was established for the prevention, screening, 
diagnosis, and treatment of lead poisoning in children residing in Massachusetts.  The 
Massachusetts Lead Law requires that all children be tested for blood lead levels once 
between the ages of 9 months and 12 months, and again at the ages of 2 and 3 years 
(CLPPP 2010a).   
Blood lead level testing data were obtained for the community of Winchester from July 
1999 though June 2010, the time period for which the most recent data were available 
from the CLPPP at the initiation of this analysis2. During this time period, there were 18 
children living in Winchester with blood lead levels equal to or greater than 10 μg/dL. 
None of these children lived adjacent to Ginn Field and only one lived within a quarter-
mile radius of the field.  Therefore, there was no geographic pattern of higher blood lead 
2 The data summarized in this report are drawn from data entered into the CLPPP before December 21, 
2010. 
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levels closer to Ginn Field that would suggest that exposure to lead from the site could 
have occurred resulting in adverse health effects.   
The most important source of elevated blood lead levels in Massachusetts children is lead 
paint in older homes.  Many homes built before 1978 have lead paint on the interior and 
exterior of the building (CLPPP 2010a).  Of the 18 children living within Winchester that 
had an elevated blood lead level during the time period of analysis, 17 lived in a house 
that was built before 1978. In addition, records indicate that lead violations were found 
and/or de-leading was conducted at six of the 18 houses (CLPPP 2010b).  Therefore, 
exposure to residential lead paint likely contributed to the children’s elevated blood lead 
levels. 
With regard to possible future exposures to contaminants in surface soil at Ginn Field, it 
is important to note that the Town of Winchester is currently implementing a series of 
flood mitigation projects.  These projects aim to reduce the frequency and severity of 
flooding along the Aberjona River by increasing its flood storage capacity and removing 
constrictions to flow. Specifically, one of these projects involves re-grading and 
deepening the channel between Manchester Road and Bacon Street, which includes the 
section of the Aberjona River that abuts Ginn Field (AECOM 2010).  This project is 
currently underway and is expected to be completed by mid-winter (Marra 2011).  As a 
result of this effort, it is expected that future deposition of contaminants from flood 
waters onto surface soil at Ginn Field would be minimal, and hence, future exposure 
opportunities to such contaminants are not expected.     
B. Exposure to Sediment 
Sediment samples were collected from the Aberjona River at four locations directly 
adjacent to Ginn Field in 2008 for the town of Winchester as part of a proposal for a 
flood mitigation program.  Samples were analyzed for metals, VOCs, PAHs, PCBs and 
total petroleum hydrocarbons (TPH) (AECOM 2010).  Because ATSDR comparison 
values do not exist for sediment, soil comparison values were used for screening 
purposes. Levels of the PAH benzo(a)pyrene in at least one sample exceeded both soil 
comparison values and typical background values (AECOM 2010; ATSDR 2010a; 
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USEPA 2010). Other PAHs were detected within background levels.  Although the 
maximum concentration of arsenic detected (32.7 ppm) exceeds soil comparison values, 
it is within the range of typical background levels and, therefore, further analysis was not 
conducted. The maximum concentration of lead detected (191 ppm) does not exceed the 
applicable soil comparison value.  Sediment samples were not tested for iron.  A 
summary of the maximum and average concentrations of contaminants detected in 
sediment samples that exceed comparison values is presented in Table 2.
During a site visit by CAP staff in January 2011, it appeared that access from Ginn Field 
to the abutting section of the Aberjona River was possible despite the presence of a chain 
link fence. A large break in the fence was noted between the front and back baseball 
fields in what is presumed to be a heavily trafficked area during the warmer months of 
the year. It is reasonable to assume that older children, including elementary aged 
children and adolescents, may play or wade in this section of the Aberjona River while 
baseball, soccer and other athletic games are being played at Ginn Field.  In addition, 
access is also possible from a paved pathway along Mystic Valley Parkway on the 
opposite side of the river. Therefore, it is possible that older children could have been 
exposed to benzo(a)pyrene via incidental ingestion of or dermal contact with sediment 
while playing or wading in the Aberjona River near Ginn Field in the past or present.   
Under the highly conservative assumption that adults, adolescents and younger children 
incidentally ingested sediment with the maximum concentration of benzo(a)pyrene that 
was detected (3.5 mg/kg) for 5 days/week for 22 weeks per year during the warmer 
months of the year for either 11 years for the child, 17 years for the adolescent or 30 
years for the adult, the estimated exposure would not result in an unusual cancer risk.  
Adverse noncancer health effects are also unlikely to occur.  Likewise, dermal exposure 
to the maximum concentration of benzo(a)pyrene detected in sediment is also not 
expected to result in an unusual cancer risk or adverse noncancer health effects.  See 
Appendices C and D for more information on the exposure dose and cancer risk 
calculations.
Dredging is planned as part of the effort to deepen the channel in this section of the river 
to mitigate future flooding.  Because PAHs are the products of incomplete combustion 
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and are ubiquitous in the environment, there is no reason to believe that the concentration 
of benzo(a)pyrene in sediment would significantly change after dredging occurs (ATSDR 
1995a). Hence, health effects are not expected to result from future exposure 
opportunities. 
C. Exposure to Surface Water 
Several investigations were conducted between 1995 and 2002 to evaluate the presence 
and transport of dissolved and suspended contaminants in surface water throughout the 
MSGRP Remedial Investigation study area.  In Reach 5, surface water samples were 
collected in 2001 and 2002 during base flow and storm flow conditions at a USGS 
gauging station (Station #01102500) located immediately upstream of Ginn Field and 
analyzed for total suspended solids and metals (Figure 3).  An additional sample was 
collected at this station in 1995 and analyzed for metals, VOCs and several additional 
water quality parameters (Tetra Tech 2005).  It should be noted that streamflow measured 
at this station during the investigation period was consistent with the 63-year averages 
recorded at this site, with the exception of the timing of the spring snowmelt peak.   
Due to the lack of health-based comparison values for surface water, results were 
compared to Massachusetts standards for public drinking water supplies (MDEP 2010).  
Water from the Aberjona River is not used as a drinking water source; and thus, this is a 
highly conservative approach because exposures to contaminants in surface water that is 
not used for drinking water are expected to be much less than exposures to those in 
drinking water consumed every day.  If Massachusetts drinking water standards were not
available, results were compared to ATSDR drinking water comparison values (ATSDR 
2010b). In the absence of both Massachusetts drinking water standards and ATSDR 
drinking water comparison values, results were compared to USEPA Regional Screening 
Levels (RSLs) for tap (drinking) water (USEPA 2010).   
Levels of sodium and thallium in at least one surface water sample collected during base 
flow conditions exceed drinking water comparison values.  The maximum concentrations 
of arsenic (maximum = 6.6 ppb; MMCL = 10 ppb), iron (maximum = 1,570 ppb; USEPA 
RSL = 26,000 ppb) and lead (maximum = 10.3 ppb; MMCL = 15 ppb) detected are 
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below comparison values (Tetra Tech 2005; MDEP 2010b).  A summary of the 
maximum and average concentrations of contaminants detected in surface water samples 
collected during base flow conditions that exceed comparison values is presented in 
Table 3. 
As discussed previously, it appears that access from Ginn Field to the abutting section of
the Aberjona River is possible either through a large break in the chain link fence that 
separates the field from the river or from a paved pathway along Mystic Valley Parkway 
on the opposite side of the river.  It is reasonable that some children may access the river 
during the warmer months of the year while athletic games are being played at Ginn 
Field. Therefore, it is possible that children could have been exposed via incidental 
ingestion of or dermal contact with sodium and thallium in the river.   
Sodium is a naturally occurring element found in water and soil.  It is an essential 
mineral, which is necessary for the normal functioning of the body and maintenance of 
body fluids. The Massachusetts guideline of 20 ppm in drinking water represents a level 
of sodium that sodium-sensitive individuals and their physicians should be aware of in 
cases where sodium intake is carefully controlled.  People who have difficulty regulating 
fluid volume as a result of several diseases such as hypertension and kidney failure are 
particularly affected by elevated levels of sodium in drinking water (MDPH 2007).  Since 
the water from the Aberjona River is not used as a drinking water source and any 
ingestion would be inadvertent and of small amounts while playing or wading, exposure 
to sodium in the surface water of the Aberjona River is not expected to result in adverse 
health effects. 
Thallium is a naturally occurring element found in trace amounts in the earth’s crust.  
Under a very conservative assumption that an adult, adolescent or younger child 
incidentally ingested surface water with the maximum concentration of thallium that was 
detected in Reach 5 (5.2 ppb) for one hour per day, 5 days per week during the warmer 
months of the year (May through September), the estimated exposures would not be 
expected to result in adverse noncancer health effects.  See Appendix E for more 
information on the exposure calculations. With regard to dermal contact, no information 
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is available on the health effects of skin contact with thallium in either people or animals 
(ATSDR 1995b). Therefore, no further evaluation was conducted.   
During storm flow conditions, several inorganic constituents (aluminum, arsenic, 
cadmium, chromium, copper, iron, lead, manganese, mercury, sodium, vanadium and 
zinc) had levels detected in at least one surface water sample that exceeded drinking
water comparison values.  A summary of the maximum and average concentrations of 
these inorganics is presented in Table 4. 
Based on site conditions, it is not expected that children would play or wade in the 
section of the Aberjona River abutting Ginn Field during storms when water flow is 
heavier and sediment with inorganic constituents is stirred up on a regular basis.  
Therefore, exposure of adolescents or younger children to contaminants via incidental 
ingestion of or dermal contact with surface water while playing or wading in the 
Aberjona River during storm flow conditions is expected to occur very infrequently or on 
rare occasions, if ever.   
Despite the low probability of exposure opportunities during storm events, MDPH did 
consider the unlikely exposure scenario of children exposed to surface water one day per 
week for 22 weeks per year during the warmer months of the year.  Assuming the 
maximum concentration of each constituent, the estimated exposures would not result in 
adverse noncancer health effects or unusual cancer concerns.  See Appendix F for more 
information on the exposure calculations.   
D. Exposure to Groundwater 
No groundwater investigations were conducted in Reaches 2 through 6 as part of the 
MSGRP Remedial Investigation (Tetra Tech 2005).  Drinking water in the community of 
Winchester is supplied by local reservoirs and the Massachusetts Water Resources 
Authority (MWRA).  All area residents use municipal water for their potable water 
supply. Groundwater is not used as a source of drinking water (J. Gibbons, Town of 
Winchester, personal communication, 2009).  As a result, the MDPH concluded that no 
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further evaluation of groundwater near Ginn Field was necessary as this exposure 
pathway could be eliminated.   
E. Exposure to Pesticides 
The MDPH evaluated past and present pesticide use at Ginn Field as potential exposure 
sources. Records of pesticides that were applied to Ginn Field were available from 2003­
2004 and obtained from the Winchester DPW.  Three different herbicides were applied to 
Ginn Field during this time period, all of which are applied as a spray: Vanquish, 
Confront and Millennium Ultra. No pesticides have been applied to Ginn Field since 
2005. 
All pesticides sold or distributed in the United States must be registered by the USEPA 
indicating that they can be used without posing unreasonable risks to people or to the 
environment, based on scientific studies.  As part of this process, the USEPA develops 
any mitigation measures or regulatory controls that are needed to effectively reduce the 
risks of the pesticide and requires that they be specified on the product label.  
Accordingly, it is a violation of federal law to use a pesticide in a manner inconsistent 
with the instructions on the product label. Furthermore, federal law also requires that the 
active ingredients of a pesticide be identified by name on the product label together with 
their percentage by weight. An active ingredient is defined as one which “prevents, 
destroys, repels or mitigates a pest, or is a plant regulator, defoliant, desiccant or nitrogen 
stabilizer.” The active ingredients of the three herbicides used at Ginn Field during 2003­
2004 consist of salts associated with clopyralid (3,6-dichloro-2-pyridinecarboxylic acid), 
triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid), dicamba (3,6-dichloro-o-anisic acid) 
and 2,4-D (2,4-dichlorophenoxyacetic acid).  Information about the toxicity and 
carcinogenicity of each of these active ingredients was obtained from the IARC and the 
USEPA Office of Pesticide Programs (See summary in Table 5).   
Clopyralid (an active ingredient of Confront and Millennium Ultra) and triclopyr (an 
active ingredient of Confront) belong to the pyridine family of herbicides, which are used 
to target broadleaf plants. Both compounds are moderately persistent in soil and are 
degraded primarily by microbial activity.  Whereas triclopyr can also be broken down by 
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sunlight or water, clopyralid can not. Neither is volatile (Tu et al 2001, USEPA 1998).  
The application of these two compounds is restricted depending on the particular 
herbicide as specified on the product label. For non-agricultural uses, a maximum of two 
broadcast applications of Millennium Ultra is allowed per year per treatment site and the 
application of Confront is limited to a maximum of 4 pints per acre per year of treatment.  
In addition, restrictions on the label of both products specify that people are not allowed 
on the treatment area during application of these herbicides and must wait to enter such 
areas until the spray has dried (Dow AgroSciences 2007, 2008, Nufarm Americas 2006; 
USEPA 2002). This restriction reduces any potential exposure of individuals by 
minimizing possible contact.  At Ginn Field, as well as at other fields managed by the 
Town of Winchester, signs are posted after a field has been sprayed to indicate that a 
pesticide has been applied (J. Gill, Town of Winchester, personal communication, 2009).  
Although potential exposures of children or adults who enter treated sites shortly after 
application may still exist, the USEPA determined that a post-application exposure 
assessment of triclopyr was not warranted because of its very low dermal toxicological 
characteristics (USEPA 1998). Similarly, clopyralid is not readily absorbed through the 
skin and also has low dermal toxicity (SERA 2004).  Based on the application and use 
restrictions as well as the low dermal toxicity of these compounds, potential exposures 
from application to recreational turf are expected to be short-term in duration with 
possible acute health effects consisting mainly of eye and/or skin irritation.  Therefore, 
long-term noncancer health effects are not expected to occur in either children or adults 
as a result of potential exposures from application of clopyralid or triclopyr to 
recreational turf at Ginn Field. 
Finally, clopyralid has been classified by the USEPA as “not likely to be carcinogenic to 
humans.”  Triclopyr has been classified by the USEPA as a Group D agent, indicating 
that insufficient information is available for classification.  Group D is generally used for 
agents with inadequate human and animal evidence of carcinogenicity or for which no 
data are available (USEPA 2009c). In this case, it was based on marginal animal 
evidence and the absence of additional support from structurally similar compounds.  
Based on this information, it is not expected that exposure to either clopyralid or triclopyr 
at Ginn Field would result in an unusual cancer risk for either children or adults.  
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Dicamba (an active ingredient of Millennium Ultra and Vanquish) and 2,4-D (an active 
ingredient of Millennium Ultra) belong to the chlorophenoxy family of herbicides, which 
are used to selectively control broadleaf weeds.  Both compounds are primarily broken 
down by microbial activity in soil with 2,4-D degrading rapidly and dicamba being 
moderately persistent.  Neither is significantly broken down by sunlight or water in soil.  
Whereas dicamba has low volatility, 2,4-D rapidly dissipates from foliage (NPIC 2002, 
2008; Nufarm Americas 2008, 2009; USEPA 2005b). As with clopyralid and triclopyr, 
the application of dicamba and 2,4-D is restricted depending on the particular herbicide 
as specified on the product label. As previously mentioned, a maximum of two broadcast 
applications of Millennium Ultra is allowed per year per treatment site for non-
agricultural uses. Repeat applications of Vanquish may be made as needed on lawns and 
recreational turf but a maximum application rate of 2 pints per acre may not be exceeded 
during the growing season. Furthermore, only protected handlers are allowed on the 
treatment area during application of either Vanquish or Millennium Ultra and both 
herbicides should be applied in a manner such that they will not contact people, either 
directly or through drift (Nufarm Americas 2004, 2006; USEPA 2005c, 2006).  Despite 
these restrictions, if post-application exposure of children or adults to dicamba or 2,4-D 
were to occur, the potential exposures are expected to be short-term in duration with 
possible acute health effects consisting of irritation of the skin, eyes and/or respiratory 
tract. While both dicamba and 2,4-D may be absorbed through the skin, both have low 
dermal toxicity (NPIC 2002, 2008; USEPA 2005d).  Therefore, long-term noncancer 
health effects are not expected from post-application exposure of children or adults to 
dicamba or 2,4-D at Ginn Field.   
With regard to carcinogenic effects, chlorophenoxy herbicides have been classified as 
Group 2B carcinogens by the IARC, indicating that they are possibly carcinogenic to 
humans.  This category is used to denote an agent for which there is limited evidence of 
carcinogenicity in humans and less than sufficient evidence of carcinogenicity in 
laboratory animals (IARC 2009).   
Dicamba, itself, was classified by the USEPA in 1996 as a Group D agent, indicating that 
it is not classifiable as to human carcinogenicity.  However, it was later considered to be 
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“Not likely to be Carcinogenic to Humans” in accordance with the EPA Final Guidelines 
for Carcinogen Risk Assessment released in 2005.  This designation was based on 
negative cancer studies in rats and mice which were tested at adequate dose levels to 
assess the carcinogenicity of dicamba (USEPA 2005d).  As a result, it is not expected that 
exposure to dicamba at Ginn Field would result in an unusual cancer risk for either 
children or adults. 
2,4-D was evaluated by the USEPA in 1988, 1992, and in 2004 due to concerns of a link 
with non-Hodgkin’s lymphoma (NHL).  Each evaluation concluded that “the data are not 
sufficient to conclude that there is a cause and effect relationship between exposure to 
2,4-D and non-Hodgkin’s lymphoma.”  In 2004, the USEPA categorized 2,4-D as a 
Group D agent, indicating that it is not classifiable as to human carcinogenicity due to 
insufficient data. Because 2,4-D is often mixed with other herbicides, it is difficult to 
determine whether carcinogenic effects may be linked to 2,4-D itself or to another 
ingredient (USEPA 2005b). MDPH examined the incidence of NHL in the community of 
Winchester and the geographic distribution of the addresses at the time of diagnosis to 
assess whether any unusual patterns might be evident in relation to Ginn Field.  This 
evaluation of cancer incidence is discussed in Section V of this HC.   
It is probably worthwhile to note that these four ingredients are common to many types of 
herbicides widely used on athletic fields and other recreational areas throughout the 
Commonwealth in accordance with label directions and with federal and state approval 
for using these herbicides in this manner (S. Kenyon, MDAR, personal communication, 
2010). Thus, it is not expected that children at Ginn Field would be at greater risk of 
exposure opportunities or health effects because of the use of these herbicides than other 
children throughout the state.   
V. ANALYSIS OF CANCER INCIDENCE 
The community of Winchester has an approximate area of 6.3 square miles and a 
population of 20,500 (U.S. Census Bureau 2000).  Childhood cancer incidence rates were 
calculated for the community of Winchester for the years 2000–2005, the time period for 
which the most recent and complete cancer incidence data were available from the 
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Massachusetts Cancer Registry (MCR) at the initiation of this analysis3. A qualitative 
review of childhood cancer in Winchester for more recent years (i.e., 2006-2008) was 
also conducted. 
A. Methods for Analyzing Cancer Incidence 
The term “childhood cancer” is used to describe a variety of diseases associated with 
abnormal cell and tissue growth in individuals aged 0 through 19 years.  These diseases 
are classified using the International Classification of Childhood Cancers (ICCC) which 
is based primarily on the tissue or cell type of the cancer (histology). This is different 
from the system used to classify adult cancers, the International Classification of 
Diseases for Oncology (ICD-O), which is based on the location in the body where the 
cancer originated (primary site).  The distinction between classification systems is 
important to consider, as the majority of pediatric cancers are disseminated when they are 
diagnosed and only the tissue of origin can be determined (Bleyer et al 2006).  When 
evaluating cancer patterns in adults, primary site cancers are treated as different diseases 
because most have different causes and risk factors associated with their development.  
However, some childhood cancers may have similar etiologies and, therefore, are often 
grouped together to reflect similarities in histology or cell type [e.g., leukemias, 
lymphomas (including Hodgkin’s disease and NHL), tumors of the central nervous 
system, and soft tissue sarcomas] (Birch and Marsden 1987; MCR 2003a; Steliarova-
Foucher et al 2005). 
As part of this investigation, the CAP reviewed incidence data available from the MCR 
for childhood cancer in Winchester.  The 6-year period from 2000-2005 constituted the 
most recent and complete cancer incidence data that were available at the time of this 
report. [Coding for cancer types in this report follows the International Classification of
Childhood Cancer (ICCC) system.  See Appendix F for the incidence coding definitions 
used in this report.] The MCR, a division within the MDPH Bureau of Health 
Information, Statistics, Research, and Evaluation, is a population-based surveillance 
3 The data summarized in this report are drawn from data entered into the MCR before April 24, 2009.  The 
numbers presented in this report may change slightly in future reports, reflecting late reported cases, 
address corrections, or other changes based on subsequent details from reporting facilities.   
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system that has been monitoring cancer incidence in the Commonwealth since 1982.  All 
new diagnoses of invasive cancer, as well as certain in situ (localized) cancers, among 
Massachusetts residents are required by law to be reported to the MCR within 6 months 
of the date of diagnosis (M.G.L. c.111. s 111b).  The MCR also gathers background 
information (e.g. gender, age, and address at time of diagnosis) on each individual 
reported. This information is kept in a confidential database.  Data are collected daily 
and reviewed for accuracy and completeness on an annual basis.  This process corrects 
misclassification of data (i.e., city/town misassignment) and deletes duplicate diagnosis 
reports. Once these steps are finished, the data for that year are considered “complete.”  
Due to the high volume of data collected, the large number of reporting facilities, and the 
six-month period between diagnosis and required reporting, the most current registry data 
that are complete will be a minimum of two years prior to the current date.  At the 
initiation of this analysis, complete data records available from the MCR included 
diagnoses that occurred from 1/1/1982 – 12/31/2005.  However, it is possible to review 
diagnosis reports for more recent years (i.e., 2006-2008), which can provide a qualitative 
review of cancer patterns in a given area.   
It should be noted that although some non-cancerous (i.e., benign) tumors are reported to 
the MCR (e.g., those diagnosed in the brain and central nervous system), these cancers 
were not included in the data summarized here.  In addition, the MCR research file may 
contain duplicate reports of individuals diagnosed with cancer.  Duplicate cases are 
additional reports of the same primary site cancer diagnosis.  In Winchester, no duplicate 
reports were identified during the years 2000–2008.  However, reports of individuals with 
multiple primary site cancers were included as separate diagnoses.  A multiple primary 
cancer case is defined by the MCR as a new cancer in a different location in the body, or 
a new cancer of the same histology as an earlier cancer, if diagnosed in the same primary 
site more than two months after the initial diagnosis (MCR 2003b).  Cancers that occur as 
a result of a primary site cancer spreading to another location in the body (i.e., metastasis) 
are not considered separate cancers and, therefore, were not included in this analysis.   
To assess whether the incidence of childhood cancer in Winchester is unusual, a statistic 
called the standardized incidence ratio (SIR) was calculated using data from the MCR.  
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The SIR is a comparison of the number of diagnoses in the community to the number of 
expected diagnoses based on the statewide rate.  Specifically, an SIR is the ratio of the 
observed number of cancer diagnoses in an area to the expected number of diagnoses 
multiplied by 100.  Age-specific statewide incidence rates were applied to the population 
distribution of the community to calculate the number of expected cancer diagnoses.4 
An SIR of 100 indicates that the number of cancer diagnoses observed in the population 
being evaluated is equal to the number of cancer diagnoses expected.  An SIR greater 
than 100 indicates that more cancer diagnoses occurred than expected and an SIR less 
than 100 indicates that fewer cancer diagnoses occurred than expected.  Accordingly, an 
SIR of 150 is interpreted as 50% more diagnoses than the expected number; an SIR of 90 
indicates 10% fewer diagnoses than expected. To help interpret an SIR, the statistical 
significance of an SIR can be assessed by calculating a 95% confidence interval (CI) to 
determine if the observed number of diagnoses is “statistically significantly different” 
from the expected number or if the difference may be due solely to chance (Rothman and 
Boice 1982). When an SIR is statistically significant, there is less than a 5% percent 
chance that the observed difference (either increase or decrease) in the rate is the result of
random fluctuation in the number of observed cancer diagnoses.  It should be noted that 
SIRs and 95% CIs are not calculated when the observed number of diagnoses is fewer 
than five. Appendix G provides a more detailed explanation of SIRs and 95% CIs.   
An SIR for childhood cancer (all types) for the community of Winchester was calculated 
for the 6-year period 2000-2005.  Because childhood cancer is relatively rare, this report 
includes rates on all childhood cancers combined in the community of Winchester.  This 
method was used to increase the power of comparisons of the incidence of childhood 
cancer in Winchester with that of the statewide experience.  In addition, because 
statewide data for the years 2006-2008 were not complete when this analysis was begun, 
expected numbers of diagnoses and incidence ratios could not be calculated for this more 
recent time period.  However, a qualitative review of childhood cancer diagnoses in 
Winchester during 2006-2008 was conducted.   
4 Using different population estimates or statistical methodologies, such as grouping ages differently or 
rounding off numbers at different points during calculations, may produce results slightly different from
those published in this report.  
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Address at the time of diagnosis was mapped for each child diagnosed with cancer in 
Winchester from 2000 to 2008 using a computerized geographic information system
(GIS) (ESRI 2009). This allowed for a qualitative evaluation of the spatial distribution of 
the residence of children diagnosed with cancer at a smaller geographic level within the 
community (i.e., neighborhoods). The MDPH is bound by law not to make public the 
names or any other information (e.g., place of residence) that could personally identify 
individuals with cancer whose diagnoses have been reported to the MCR (M.G.L. c.111. 
s. 24A). Therefore, for confidentiality reasons, it is not possible for the MDPH to release 
maps showing the locations of individuals diagnosed with cancer in public reports.  
However, a summary of the evaluation of geographic distribution with any notable 
findings is presented in this report. 
To better characterize the pattern of childhood cancer incidence in Winchester, diagnosis-
specific information available from the MCR relating to the type of cancer, date of 
diagnosis, age at diagnosis, and gender was reviewed for each child diagnosed with 
cancer during 2000-2008. This information is discussed in the context of known or 
established cancer risk factors and incidence patterns in the general population.  It should 
be noted, however, that very little is known about the etiology of childhood cancer.  
Unlike many cancers of adults, there are no avoidable risk factors (such as smoking or 
exposure to hazardous chemicals in the workplace) that are known to influence a child's 
risk of developing cancer. 
B. Results of Cancer Incidence Analysis 
1. Childhood Cancer Incidence in Winchester, 2000-2005 
Table 6 summarizes the incidence of childhood cancer for the community of Winchester 
during the six-year time period of 2000-2005.  Overall, cancer occurred slightly more 
often than expected among children aged 0-19 years in Winchester during this time
period (7 diagnoses observed compared to about 6 expected).  This difference was not 
statistically significant (SIR = 121, 95% CI = 49-250).  A separate evaluation by gender 
revealed that a greater number of males were diagnosed with cancer than expected.  
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Among males, six diagnoses were observed compared to slightly more than three 
expected (SIR = 195). This elevation was not statistically significant (95% CI = 71-423).   
The cancer types diagnosed among these 7 children during 2000-2005 included Central 
Nervous System and Miscellaneous Intracranial and Intraspinal Neoplasms [CNS tumors 
(n = 3)], Leukemias, Myeloproliferative Diseases and Myelodysplastic Diseases (n = 2), 
Neuroblastomas and Other Peripheral Nervous Cell Tumors (n = 1) and Germ Cell, 
Trophoblastic and Other Gonadal Neoplasms (n = 1).  The number of diagnoses per year 
varied between zero and three with at least one diagnosis occurring in five of the six 
years. 
The geographic distribution of the place of residence at the time of diagnosis for these 7 
children was generally consistent with the population density in Winchester.  None of the 
children lived within a ½-mile radius of Ginn Field at the time of their diagnosis.  No 
unusual patterns were observed relative to space (i.e., in the vicinity of Ginn field) or 
time (i.e., dates of diagnosis).   
2. Childhood Cancer Incidence in Winchester, 2006-2008 
As stated earlier, expected numbers of diagnoses and SIRs cannot be calculated for more 
recent years because the statewide data for the years 2006 to present were not complete at 
the time of this analysis.  This section, however, provides a qualitative review of 
childhood cancer in Winchester from 2006 to 2008.     
From January 2006 to December 2008, six children (four males and two females) 
reported to the MCR as residents of Winchester were diagnosed with cancer.  The cancer 
types diagnosed among these six children included Leukemias, Myeloproliferative 
Diseases and Myelodysplastic Diseases (n = 2), Malignant Bone Tumors (n = 1), Soft 
Tissue and Other Extraosseous Sarcomas (n = 1), Germ Cell, Trophoblastic and Other 
Gonadal Neoplasms (n = 1), and Other Malignant Epithelial Neoplasms and Malignant 
Melanomas (n = 1).  Of the six diagnoses that were reported during this three-year time 
period, three occurred during 2006, one occurred in 2007, and two occurred in 2008.   
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Although some diagnoses occurred among children whose residences at the time of 
diagnosis were in relative close proximity to one another, the geographic distribution of 
the place of residence at the time of diagnosis for these 6 children was generally 
consistent with the population density in Winchester.  Three of the children lived within a 
½-mile radius of Ginn Field at the time of their diagnosis.  It should be noted that the 
places of residence for these three diagnoses were all located within areas of high 
population density. Overall, no unusual spatial patterns or concentrations of diagnoses 
were noted in the vicinity of the field or elsewhere in the community.     
3. Incidence in Winchester by Type of Childhood Cancer 
In general, several of the types of cancer diagnosed among children in Winchester during 
2000-2008 are among the most common cancer types diagnosed among children (i.e., 
ages 0-19). Specific information on each of the seven cancer types diagnosed among 
children in Winchester during the time period evaluated is provided in the following 
sections. 
a. Leukemias, Myeloproliferative Diseases and Myelodysplastic Diseases 
Leukemia is a cancer of the bone marrow and blood.  It is the most common type of 
childhood cancer, accounting for slightly more than 30% of all cancers diagnosed in 
children (ACS 2009a).  Leukemia was the most common cancer type diagnosed among 
children in Winchester during 2000-2008.  Of the 13 children diagnosed with cancer 
during this time period, four (31%) were diagnosed with leukemia.  No temporal trends 
were observed among these diagnoses.   
In children, leukemia is classified into four major subtypes: lymphoid leukemia, acute 
myeloid leukemia, chronic myeloproliferative disease, and myelodysplastic syndrome
(Steliarova-Foucher et al 2005).  In Massachusetts, the majority of childhood leukemia 
diagnoses are of the lymphoid leukemia subtype (MCR 2003a).  During 2000-2008, all 
four diagnoses of leukemia in Winchester were lymphoid leukemias.  According to the 
American Cancer Society (ACS), the risk for lymphoid leukemia is highest in children 
between 2 and 4 years of age.  The risk then declines slowly until the mid-20s (ACS 
  
 
  
 
   
2009b). One of the four children diagnosed in Winchester fits the pattern suggested by 
the ACS and was diagnosed between the ages of 2 and 4, whereas two children were 
between the ages of 5 and 10 years of age at diagnosis and the fourth child was between 
the ages of 11 and 19 years old at diagnosis. 
b.	 Central Nervous System and Miscellaneous Intracranial and Intraspinal 

Neoplasms

Central nervous system and miscellaneous intracranial and intraspinal neoplasms (CNS 
tumors) include tumors that arise from the brain, spinal cord, and other sites within the
skull and spinal cord. Nationally and statewide, these tumors are the second most 
common type of cancer in children. CNS tumors account for about 21% of all childhood 
cancers in the United States and about 17% of all childhood cancers in Massachusetts 
(MCR 2003a; ACS 2009c). In Winchester, three (23%) children were diagnosed with a 
CNS tumor from 2000-2008.  No temporal trends were observed, with the number of 
diagnoses per year varying between zero and two.     
There are several different types of CNS tumors.  Gliomas are a general classification of 
CNS tumors that include a variety of types, named for the cells from which they arise: 
astrocytomas, oligodendrogliomas, and ependymomas.  According to the ACS, gliomas 
account for approximately 80% of all malignant brain and CNS tumors and astrocytomas 
account for about half of all childhood brain tumors.  Additional types of CNS tumors 
include primitive neuroectodermal tumors (PNETs), medulloblastomas, and other rare 
types (ACS 2009c). In Winchester, two children were diagnosed with gliomas and one 
child was diagnosed with an astrocytoma.  According to the American Brain Tumor 
Association (ABTA), CNS tumors typically affect children under 15 years of age and 
older adults (ABTA 2008). Of the three children diagnosed with neoplasms of the CNS 
in Winchester from 2000-2008, all were diagnosed at ages younger than 15.   
c.	 Germ Cell, Trophoblastic and Other Gonadal Neoplasms
Germ cell (egg or sperm), trophoblastic (cells outside an early embryo) and other gonadal 
(ovarian or testicular) neoplasms arise from reproductive cells.  This group of cancers 
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accounts for about 7% of all cancers occurring among children less than 20 years old in 
the United States.  The highest incidence rates of these types of neoplasms occur in 
adolescents between 15 and 19 years old, accounting for 16% of all cancers diagnosed in 
this age group. The majority (about 60%) of germ cell, trophoblastic, and other gonadal 
neoplasms are gonadal germ cell tumors (Ries et al 1999).  The Massachusetts statewide 
experience is consistent with these national statistics (MCR 2003a).  In Winchester, two 
children were diagnosed with malignant gonadal germ cell tumors during 2000-2008.  
Both were adolescents between the ages of 15 and 19 years old at the time of diagnosis.   
d. Neuroblastoma and Other Peripheral Nervous Cell Tumors 
Neuroblastoma occurs in the sympathetic nervous system, which regulates involuntary 
activities of the heart muscle, smooth muscle, and glands.  It develops in certain types of 
developing nerve cells found in an embryo or fetus.  Neuroblastoma accounts for over 
97% of sympathetic nervous system tumors (Ries et al 1999).  Nationally and statewide, 
neuroblastoma accounts for about 7% of all cancers in children (ACS 2008, 2009c; MCR 
2003a). Neuroblastoma is by far the most common cancer in infants (less than 1 year 
old) and is rarely found in children older than 10 years (ACS 2008).  In Winchester, one 
child was diagnosed with neuroblastoma during 2000-2008.  This child was less than 1 
year of age at the time of diagnosis.   
e. Malignant Bone Tumors
Malignant bone tumors account for about 5% of all childhood cancers in Massachusetts, 
which is consistent with national statistics (MCR 2003a; Ries et al 1999).  Osteosarcoma
is the most common type of cancer that develops in bone and comprises about 66% of 
malignant bone tumors diagnosed in children in Massachusetts (ACS 2009d; MCR 
2003a). Most osteosarcomas occur in children and young adults between the ages of 10 
and 30. Teenagers comprise the most commonly affected age group and are at the 
highest risk during their “growth spurt” (ACS 2009d).  In Winchester, one child was 
diagnosed with osteosarcoma during 2000-2008.  This child was a teenager at the time of 
diagnosis. 
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f. Soft Tissue and Other Extraosseous Sarcomas 
Soft tissue sarcomas are cancers that develop in connective tissues, such as muscle, fat 
and blood vessels, and can occur at any site throughout the body.  Between 1990 and 
1999, soft tissue sarcomas accounted for about 7% of all childhood cancers in 
Massachusetts, which coincides with national trends (MCR 2003a; Ries et al 1999).  
There are many different types of soft tissue sarcomas.  The most common type of 
childhood soft tissue sarcoma is rhabdomyosarcoma, which develops in skeletal muscle.  
About 3% of childhood cancers are rhabdomyosarcomas (ACS 2007).  According to the 
National Cancer Institute (NCI), the incidence of soft tissue sarcomas is highest among 
young children during infancy and children aged 15 to 19 years old (Ries et al 1999).  In 
Winchester, one child was diagnosed with a soft-tissue sarcoma (rhabdomyosarcoma) 
during 2000-2008. This child was less than 1 year of age at the time of diagnosis.   
g. Other Malignant Epithelial Neoplasms and Malignant Melanomas 
This group of cancers includes several different types including adrenocortical 
carcinomas, thyroid carcinomas, nasopharyngeal carcinomas, malignant melanoma, and 
skin cancers. It also includes a category of cancers referred to as other and unspecified 
carcinomas (Steliarova-Fucher et al 2005).  Carcinomas are many different cancers that 
develop from epithelial cells that form the lining of organs.  The age-specific incidence 
rate of carcinomas and other malignant epithelial neoplasms among children in 
Massachusetts was highest among adolescents 15-19 years old (MCR 2003a).  Of the 13 
children diagnosed with cancer in Winchester during 2000-2008, one was diagnosed with 
an unspecified carcinoma as an adolescent.  It was noted that this child also had a 
previous cancer diagnosis prior to the time period evaluated.   
4. Incidence of Non-Hodgkin’s Lymphoma in Winchester, 2000-2005 
The incidence of non-Hodgkin’s lymphoma among adults and children in the community 
of Winchester during 2000-2005 was reviewed in response to concerns of a possible 
association with the active pesticide ingredient 2,4-D.  During this time period, the 
incidence among both males and females was slightly greater than expected based on the 
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 statewide cancer experience, but neither elevation was statistically significant.  A total of
20 males were diagnosed during this time period compared to about 16 expected (SIR = 
124, 95% CI = 76-191). Among females, 18 diagnoses were observed and about 16 
diagnoses were expected (SIR = 113, 95% CI = 67-179).  No temporal trends were 
observed, with the number of diagnoses per year varying between four and eleven.   
The geographic distribution of the place of residence at the time of diagnosis for those 
diagnosed with NHL during this time period was generally consistent with the population 
density pattern in Winchester.  Six individuals lived within a ½-mile radius of Ginn Field 
at the time of their diagnosis.  However, the places of residence for these six individuals 
were all located within areas of high population density.  In addition, the ages at the time 
of diagnosis of those individuals diagnosed in Winchester during this time period 
followed what would be expected based on national trends.  According to the ACS, 
approximately 90% to 95% of diagnoses of NHL occur in adults. The average age at 
diagnosis is in the 60s, and around half of patients are older than 65 (ACS 2009e).  In 
Winchester, all of the diagnoses during this time period occurred in adults.  The average 
age was 68 years and 61% of those diagnosed were older than age 65.  Overall, no 
unusual spatial patterns or concentrations of diagnoses were noted in the vicinity of Ginn 
Field or elsewhere in the community. 
VI. DISCUSSION 
At the request of a concerned resident and the Winchester BOH, the MDPH conducted an 
evaluation of possible environmental exposures related to Ginn Field and the incidence of 
cancer in the community of Winchester.  A detailed evaluation of the pattern of cancer in 
children was the primary focus.  Concerns focused on potential exposures to 
contaminants in the surface water and sediment of the section of the Aberjona River that 
abuts the field as well as to contaminants in surface soil deposited by flood waters.   
As part of this HC, the MDPH conducted a quantitative and qualitative evaluation of 
childhood cancer for the community of Winchester during 2000-2008 and examined the 
pattern of childhood cancer to identify any unusual concentrations of diagnoses.  In 
addition, available environmental information for the stretch of the Aberjona River near 
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Ginn Field was assessed to determine possible pathways of exposure for adults and 
children visiting or playing at the field and available records of pesticide applications to 
the field were reviewed to determine if any active ingredients have been associated with 
long-term noncancer or carcinogenic effects.     
Some potential exposure pathways relative to surface soil and sediment may have 
occurred in the past and could occur presently.  However, based on highly conservative 
exposure assumptions, adverse health effects or unusual cancer risks are not expected to 
occur from exposure opportunities to constituents in sediment or surface soil.  In the 
future, exposure to contaminants in surface soil deposited by flood waters may be 
eliminated as a pathway based on current projects to deepen the section of the Aberjona
River abutting Ginn Field to reduce the frequency and severity of any future flooding.  
Likewise, future exposures to constituents in sediment are unlikely to cause health 
concerns given that there are no known ongoing sources and, hence, similar or lower 
concentrations are expected in the future.  
It should be noted that no surface soil sample data specific to Ginn Field were available 
for review in this HC. The analyses conducted in this HC are based on the assumption 
that the concentrations of contaminants detected in the surface soil samples collected 
from floodplain soils located south of Bacon Street are representative of the floodplain 
soils at Ginn Field. It should also be noted that Ginn Field is primarily covered by grass 
with only a few areas of exposed dirt, such as the baseball diamonds, which would 
minimize incidental ingestion of soil by an individual.    
Some potential exposure pathways relative to surface water may have occurred in the 
past and could occur presently or in the future.  During base flow conditions, 
opportunities for exposure to sodium and thallium in surface water may be possible.  
During storm flow conditions, opportunities for exposure to several constituents may be 
possible, though unlikely. However, based on highly conservative exposure 
assumptions, adverse health effects or unusual cancer risks are not expected to result 
from any of these potential pathways.   
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Potential groundwater pathways were eliminated because it was not and is not used as a 
source of drinking water in Winchester.  Drinking water is provided by a combination of 
local reservoirs and the MWRA.   
Three different herbicides, containing a total of four active ingredients, were applied to 
Ginn Field in 2003-2004 (no pesticides have been applied since then).  These ingredients 
are common to many types of herbicides and widely used on athletic fields and other 
recreational areas throughout Massachusetts.  Long-term noncancer health effects are not 
expected to occur from opportunities for post-application exposure of children or adults 
to pesticides applied at Ginn Field during this time period due to the restricted frequency 
of use as well as the toxicological characteristics of clopyralid, triclopyr, dicamba and 
2,4-D. The MDPH examined the incidence of NHL within the community of Winchester 
during 2000-2005. During this 6-year time period, the incidence of NHL among both 
males and females was slightly greater than expected but not statistically significant.  No
temporal trends were observed and no unusual spatial patterns were noted in the vicinity 
of the field or elsewhere in the community.   
As part of this investigation, the CAP reviewed incidence data available from the MCR 
for childhood cancer in Winchester during the six-year time period, 2000-2005.  This was 
the time period for which the most recent and complete cancer incidence data were 
available at the initiation of this analysis.  A qualitative review of childhood cancer in 
Winchester for more recent years (i.e., 2006-2008) was also conducted.   
In general, Winchester experienced a slightly elevated incidence of childhood cancer 
during 2000-2005 that was not statistically significant.  The incidence among females 
was slightly less than expected, whereas that among males was more than expected but 
not statistically significant.  Between 2000 and 2008, a total of 13 children in Winchester 
were diagnosed with the following seven types of cancer: leukemia, CNS tumors, 
malignant gonadal germ cell tumors, neuroblastoma, cancer of the bone, soft tissue 
sarcoma, and unspecified carcinoma.
In general, the types of cancers that occur in children vary greatly from those seen in 
adults. Leukemias, brain and CNS tumors, lymphomas, bone cancers, soft tissue 
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sarcomas, kidney cancers and eye cancers are the most common cancers in children.  In 
contrast, the most common cancers among adults include skin, prostate, breast, lung, and 
colorectal cancers (ACS 2009f). In Massachusetts, a total of 1,720 children between the 
ages of 0 and 19 were diagnosed with cancer between 2000 and 2005. Leukemia was the 
most common type of childhood cancer, followed by cancers of the brain and CNS.  
Other common childhood cancers among Massachusetts children include Hodgkin’s 
disease, NHL, soft tissue sarcoma, neuroblastoma, and some bone cancers.  For the most 
part, the distribution of cancer types diagnosed among children in Winchester during 
2000-2008 was consistent with state and national trends. 
In addition, analysis of the geographic distribution of place of residence for children in
Winchester diagnosed with cancer during 2000-2008 did not reveal any atypical spatial 
patterns that would suggest a common factor (environmental or non-environmental) is 
related to the incidence. That is, no apparent concentrations of diagnoses were observed 
in the vicinity of Ginn Field or elsewhere in the community that might suggest an 
association with a common environmental factor.  Although some diagnoses during 
2006-2008 occurred among children whose residences at the time of diagnosis were in 
relative close proximity to one another, the geographic distribution was generally 
consistent with population density.   
Unlike many cancers of adults, there are no avoidable risk factors (such as smoking or 
exposure to hazardous chemicals in the workplace) that are known to influence a child's 
risk of developing cancer. Unfortunately, the causes of childhood cancers are largely 
unknown. A few conditions, such as Down syndrome, other specific chromosomal and 
genetic abnormalities, and ionizing radiation exposures, explain a small percentage of
diagnoses (NCI 2008). According to the NCI, environmental causes of childhood cancer 
have long been suspected but difficult to identify, partly because cancer in children is rare 
and because it is difficult to identify past exposure levels in children, particularly during 
potentially important periods such as pregnancy or even prior to conception.  In addition, 
each of the distinctive types of childhood cancers develops differently, with a potentially 
wide variety of causes (NCI 2008). 
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According to the NCI, cancer is more common in male children than in female children.  
Based on data from the 1990s, childhood cancers are most prevalent among the white 
population followed by the Hispanic, Asian/Pacific Islander, African-American, and 
American Indian populations in the United States (Bleyer et al 2006).  In addition, the 
types of cancer diagnosed among younger children (0-5 years of age) often vary from 
those diagnosed among older adolescents (15-19 years of age).  For example, leukemias 
are most frequently diagnosed in younger children (with most diagnoses occurring before 
the age of 5) whereas lymphomas are the most frequently diagnosed type of cancer 
among adolescents (MCR 2003a; Bleyer et al 2006).   
According to ACS statistics, cancer is the second leading cause of death in Massachusetts 
and the United States. Not only will one out of three women and one out of two men 
develop cancer in their lifetime, but cancer will affect three out of every four families.
For this reason, cancers often appear to occur in “clusters,” and it is understandable that 
someone may perceive that there are an unusually high number of cancer cases in their 
neighborhood or community.  Upon close examination, many of these “clusters” are not 
unusual increases, as first thought, but are related to such factors as local population 
density, variations in reporting or chance fluctuations in occurrence.  In other instances, 
the “cluster” in question includes a high concentration of individuals who possess related 
behaviors or risk factors for cancer.  Some, however, are unusual; that is, they represent a 
true excess of cancer in a workplace, a community, or among a subgroup of people.  A 
suspected cluster is more likely to be a true cancer cluster if it involves a large number of 
cases of one type of cancer diagnosed in a relatively short time period rather than several 
different types diagnosed over a long period of time (i.e., 20 years), a rare type of cancer 
rather than common types, and/or a large number of cases diagnosed among individuals 
in age groups not usually affected by that cancer.  These types of clusters may warrant 
further public health investigation. 
VII. CHILD HEALTH CONSIDERATIONS 
The MDPH recognizes that the unique vulnerabilities of infants and children demand 
special emphasis in communities faced with contamination in their environment.
Children are at a greater risk than adults for certain kinds of exposure to hazardous 
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substances emitted from waste sites.  They are more likely to be exposed because they 
play outdoors and because they often bring food into contaminated areas.  Because of 
their smaller stature, they might breathe dust, soil, and heavy vapors close to the ground.  
Children are also smaller, resulting in higher doses of contaminant exposure per body 
weight. The developing body systems of children can sustain permanent damage if 
certain toxic exposures occur during critical growth stages.  Most importantly, children 
depend completely on adults for risk identification and management decisions, housing 
decisions, and access to medical care.   
 
The incidence and patterns of cancer among children in Winchester are discussed in 
Section V (“Analysis of Cancer Incidence”) of this report.  As mentioned previously, risk 
of exposure to contaminants in surface soil exists for children playing sports or visiting 
Ginn Field. Risk of exposure to contaminants in sediment and surface water also exists 
for children who wade or play in the section of the Aberjona River that abuts Ginn Field.  
However, it is unlikely that anyone would have contact with surface soil, sediment or 
surface water for a sufficient frequency and duration of time to result in health effects.   
 
In addition, past exposure of children to pesticides that were sprayed at Ginn Field prior 
to 2006 may have been possible.  However, based on the restricted frequency of use as 
well as the toxicological characteristics and carcinogenicity of the active ingredients of 
the pesticides used at Ginn Field, post-application exposure of children is not expected to 
harm their health.   
VIII. LIMITATIONS 
As part of this HC, descriptive health outcome data for cancer was analyzed to determine 
whether the pattern or occurrence of childhood cancer in the community of Winchester is 
unusual. The pattern of diagnoses of childhood cancer was evaluated in a geographical 
context in relation to available information about risk factors to determine whether 
further investigation seems warranted.  Information from descriptive analyses, which may 
suggest a common etiology (or cause) is possible, can serve to identify areas where 
further analyses may be needed.  Inherent limitations in the available data and this type of 
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analysis make it impossible to determine the precise casual relationships or synergistic 
roles that may have contributed to the development of individual cancers in this 
community. Cancers in general have a variety of risk factors known or suggested to be 
related to the etiology of the disease that could not be evaluated in this investigation.  It is 
beyond the scope of this investigation to determine the causal relationship of these factors 
and the development of childhood cancer in Winchester.  Also, this type of analysis 
cannot determine what may have caused cancer in any one particular individual.   
IX. CONCLUSIONS 
Based on the MDPH’s evaluation of the available environmental data, the exposure 
pathway analysis, and risk factor information related to childhood cancer, MDPH 
concludes that: 
	 Incidentally eating or touching soil at Ginn Field in the past, present or 
future is not expected to harm the health of adults, adolescents or younger 
children playing at or visiting the field. The reason for this is because, based on 
available information and conservative assumptions about the frequency and 
duration of potential exposures, levels of metal contaminants that could get into 
an adult’s or a child’s body in the past or present are below levels that would 
harm their health.  In the future, deposition of contaminants from flood waters 
onto the soil at Ginn Field is expected to be minimal after the channel is deepened 
in this section of the Aberjona River.   
	 Incidentally eating or touching sediment while playing or wading in the 
Aberjona River near Ginn Field in the past, present or future is not expected 
to harm the health of adults, adolescents or younger children.  The reason for this 
is because, based on available information and conservative assumptions about 
the frequency and duration of potential exposures, levels of chemical 
contaminants that could get into an adult’s or a child’s body in the past or present 
are below levels that would harm their health.  Likewise, future exposures to 
constituents in sediment are unlikely to cause health concerns given that there are 
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no known ongoing sources and, hence, similar or lower concentrations are 
expected in the future. 
 Incidentally drinking or touching surface water while playing or wading in 
the Aberjona River near Ginn Field in the past, present or future is not 
expected to harm the health of adults, adolescents or younger children. The reason 
for this is because, based on available information and conservative assumptions 
about the frequency and duration of potential exposures, levels of chemical 
contaminants that could get into an adult’s or a child’s body during either base 
flow or storm flow conditions are below levels that would harm their health. 
 Drinking tap water in the community of Winchester was/is not impacted by 
contaminants from Superfund sites and the Aberjona River in the past, 
present or future and, therefore, is not expected to harm people’s health.  The 
reason for this is because groundwater in the community of Winchester is not 
used as a source of drinking water. Rather, the drinking water is supplied by local 
reservoirs and the Massachusetts Water Resources Authority.   
 Incidentally touching pesticides that were sprayed at Ginn Field in the past is 
not expected to harm people’s health.  The reason for this is because, based on the 
restricted frequency of use as well as the toxicological characteristics of the 
pesticides used at Ginn Field, post-application exposure of adults or children is 
not expected to harm their health.  No pesticides have been applied to Ginn Field 
since 2005. 
 Within the community of Winchester, the incidence of childhood cancer 
during 2000-2005 occurred slightly more often than expected.  This difference 
was not statistically significant. The incidence among females was slightly less 
than expected, whereas that among males was more than expected but not 
statistically significant.  The histologies (cell types) and ages at diagnosis were 
generally consistent with state and national trends.   
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	 Within the community of Winchester, the geographic distribution of place of 
residence for children diagnosed with cancer during 2000-2008 did not reveal 
any atypical spatial patterns. Although some diagnoses during 2006-2008 
occurred among children whose residences at the time of diagnosis were in 
relative close proximity to one another, the geographic distribution of the place of 
residence at the time of diagnosis was generally consistent with population 
density. 
X. RECOMMENDATIONS 
The MDPH recommends no further investigation of childhood cancer incidence in 
Winchester at this time.   
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Table 1
 
Maximum and Average Concentration of Contaminants Detected in Surface Soil Samples that Exceed Comparison Values
 
Aberjona River, Reach 5
 
Winchester, Massachusetts
 
Contaminant Frequency of Detection 
Maximum 
Concentration 
(ppm) 
Sample Name 
Average 
Concentration
(ppm) 
Soil Comparison Value (ppm) Background Soil Level 
(ppm) 
Arsenic 7 /  9  98 AJRW22 46.4 Chronic EMEG (child) = 20 
Chronic EMEG (adult) = 200 
CREG = 0.5 <0.1 - 73*
20 (natural soil)† 
Chromium 9 / 9 90 AJRW18 39.9 
Chronic EMEG (child) = 50 
Chronic EMEG (adult) = 700 
1 - 1,000* 
30 (natural soil)† 
Lead 9 / 9  930 AJRW16 298  EPA RSL (residential) = 400 
<10 - 300* 
100 (natural soil)† 
*Observed Range for the Eastern United States (east of 96th meridian). USGS. 1  984. Shacklette HT, Boerngen JG. Element Concentrations in Soils and Other Surficial 
Materials of the Conterminous United States. U.S. Geologica  l Survey Professional Paper 1270. 
†MDEP. 2002  . Background Levels of Polycyclic Aromatic Hydrocarbons and Metals in Soil  . Office of Research and Standards. 
ppm = parts per million 
< = less than 
Comparison Values: 
Chronic EME  G (adult/child) = Environmental Media Evaluation Guide (i.e., for adult or childhood exposures greater than 1 year) (ATSDR 2005, 2010a)
 
CREG   = Cancer Risk Evaluation Guide for 1 x 10-6 excess cance  r risk (ATSDR 2005, 2010a)
 
EPA RSL = EPA Region 3 Regional Screening Level for soil (USEPA 2010)
 
Data Sources: 
Tetra Tech N  US,  Inc. (Tetra Tech). 2005. Draft Final MSGRP Remedial Investigation Report: Industri-Plex Site, Wobu  rn, Massachusetts. March. 
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Table 2
 
Maximum and Average Concentration of Contaminants Detected in Sediment Samples that Exceed Comparison Values
 
Aberjona River
 
Winchester, Massachusetts
 
Contaminant 
Frequency 
of
Detection 
Maximum 
Concentration
(ppm) 
Sample Name 
Average
Concentration
(ppm) 
Soil Comparison Value (ppm) Background Soil Level
(ppm) 
Arsenic /4 4 32.7 SDISCA-1 18.2 Chronic EMEG (child) = 20 
CREG = 0.5 
Chronic EMEG (adult) = 200 
<0.1 - 73*
20 (natural soil)†† 
Benzo(a)anthracene 44 / 3.7 SDISCA-1 2.7  
EPA RSL (residential) = 0.15
CREG = 1** 
0.005 - 0.02 (rural soil)† 
0.169 - 59 (urban soil)† 
2 (natural soil)†† 
Benzo(a)pyrene 4 /  4  3.5 SDISCA-1 2.4 CREG = 0.1 
0.002 - 1.3 (rural soil)† 
0.165 - 0.22 (urban soil)† 
2 (natural soil)†† 
Benzo(b)fluoranthene 4 / 4 3.4 SDISCB-3 2.4 
EPA RSL (residential) = 0.15
CREG = 1** 
0.02 - 0.03 (rural soil)† 
15 - 62 (urban soil)† 
2 (natural soil)†† 
Benzo(k)fluoranthene 4 / 4 3.4 SDISCA-1 2.0 
EPA RSL (residential) = 1.5
CREG = 1** 
0.01 - 0.11 (rural soil)† 
0.3 - 26 (urban soil)† 
1 (natural soil)†† 
Chromium 44 / 119 SDISCA-1 68 
Chronic EMEG (child) = 50 
Chronic EMEG (adult) = 700 
1 - 1,000* 
30 (natural soil)†† 
Dibenzo(a,h)anthracene / 44 0.44 SDISCB-3 0.31 
EPA RSL (residential) = 0.015 
CREG = 0.02** 
0.5 (natural soil)†† 
Indeno(1,2,3-cd)pyrene 4 / 4 2.1 SDISCA-1 1.4 
EPA RSL (residential) = 0.15
CREG = 1** 
0.01 - 0.015 (rural soil)† 
8.0 - 61 (urban soil)† 
1 (natural soil)†† 
*Observed range for the Eastern United States (east of 96th meridian). USGS. 1984. Shacklette HT, Boerngen JG. Element Concentrations in Soils and Other Surficial 
Materials of the conterminous United States. U.S. Geological Survey Professional Paper 1270. 
† ATSDR. 1995. Toxicological profile for polyaromatic hydrocarbons. Atlanta: U.S. Department of Health and Human Services. 
†† MDEP. 2002. Background levels of polycyclic aromatic hydrocarbons and metals in soil. Office of Research and Standards.
ppm = parts per million 
< = less than 
Comparison Values: 
Chronic EMEG (adult/child) = Environmental Media Evaluation Guide (i.e., for adult or childhood exposures greater than 1 year) (ATSDR 2005, 2010a)
 
CREG = Cancer Risk Evaluation Guide for 1 x 10-6 excess cancer risk (ATSDR 2005, 2010a)
 
CREG** = Estimated CREG using toxicity equivalency factors relative to benzo(a)pyrene developed by USEPA.
 
EPA RSL = EPA Region 3 Regional Screening Levels for soil (USEPA 2010)
 
Data Sources: 
AECOM. 2010. Massachusetts Environmental Policy Act, Final Environmental Impact Report, EOEA File No. 13046, Aberjona River Flood Mitigation Program,
Town of Winchester, MA. February 12.
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Contaminant 
Frequency of 
Detection 
Maximum 
Concentration 
(ppb) 
 Date of Sample 
Average 
Concentration 
(ppb) 
Drinking Water Comparison Value 
(ppb) 
Sodium 17 / 17 141,000 (J) 2/15/2002 80,100  MDEP Guideline = 20,000 
Thallium 1 / 16 5.2 1/4/2002 2.0 MDEP MMCL = 2 
   
     
 
 
Table 3
 
Maximum and Average Concentrations of Contaminants Detected in Surface Water Samples During Base Flow Conditions
 
that Exceed Comparison Values
 
Aberjona River, Reach 5
 
Winchester, Massachusetts
 
(J) Exact value not quantified in laboratory analytical results 
ppb = pa  rts per billion 
Comparison Values: 
MDEP Guideline = Massachusetts Department of Environmental Protection Drinking Water Guideline (MDEP 2010)
 
MDEP MMCL = Massachusetts Depa  rtment of Environmental Protection Massachusetts Maximum Contaminant Level (MDEP 

2010)
 
Data Sources: 
Tetra Tech NUS  , Inc  . (Tetra Tech). 2005. Draft Final MSGRP Remedial Investigation Report: Industri-Plex Site, Woburn  ,
Massachusetts. March. 
Notes: 
Due to the lack of health-bas  ed comparison values for surface water, resul  ts were compar  ed to Massachusetts drinking water 
standards.    When a Massachusetts drinki  ng water st  andard was not available, results were compared to ATSDR drinking water 
comparison 
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Table 4
 
Maximum and Average Concentrations of Contaminants Detected in Surface Water Samples During Storm Flow Conditions that 

Exceed Comparison Values
 
Aberjona River, Reach 5
 
Winchester, Massachusetts
 
Contaminant Frequency of Detection 
Maximum 
Concentration 
(ppb) 
Date of Sample 
Average
Concentration
(ppb) 
Drinking Water Comparison Value 
(ppb) 
Aluminum 51 88/ 58,300 5/16/2002 1,490 Chronic EMEG (child) = 10,000 
Chronic EMEG (adult) = 40,000 
Arsenic 85 / 88 427 (J) 5/16/2002 15.6 MDEP MMCL = 10 
Cadmium 4 / 88 25.5 (J) 5/16/2002 0.63 MDEP MMCL = 5 
Chromium 70 / 88 1,070 5/16/2002 26.7 MDEP MMCL = 100 
Copper 72 / 88 1,320 5/16/2002 39.6 MDEP MMCL, Action Level = 1,300 
Iron 88 / 88 145,000 5/16/2002 4,330 EPA RSL = 26,000 
Lead 65 / 88 1,420 5/16/2002 38.5 MDEP MMCL, Action Level = 15 
Manganese 88 / 88 14,600 5/16/2002 478 
RMEG (child) = 500 
RMEG (adult) = 2,000 
Mercury 25 / 83 3.7 5/16/2002 0.12 MDEP MMCL = 2 
Sodium 88 / 88 80,000 4/26/2002 38,400 MDEP Guideline = 20,000 
Vanadium 42 / 88 170 5/16/2002 4.9 
Int. EMEG (child) = 100 
Int. EMEG (adult) = 400 
Zinc 88 / 88 5,070 5/16/2002 153 
Chronic EMEG (child) = 3,000 
Chronic EMEG (adult) = 10,000 
(J) Exact value not quantified in laboratory analytical results 
ppb = parts per billion 
Comparison Values: 
Chronic EMEG (adult/child) = Environmental Media Evaluation Guide (i.e., for adult or childhood exposures greater than 1 year) (ATSDR
 
2005, 2010b)
 
Intermediate EMEG (adult/child) = Environmental Media Evaluation Guide (i.e., for adult or childhood exposures between 14 days and 1 year) 

(ATSDR 2005, 2010b)
 
MDEP Guideline = Massachusetts Department of Environmental Protection Drinking Water Guideline (MDEP 2010)
 
MDEP MMCL = Massachusetts Department of Environmental Protection Massachusetts Maximum Contaminant Level (MDEP 2010)
 
EPA RSL = EPA Region 3 Regional Screening Levels for tap water (USEPA 2010)
 
Data Sources: 
Tetra Tech NUS, Inc. (Tetra Tech). 2005. Draft Final MSGRP Remedial Investigation Report: Industri-Plex Site, Woburn, Massachusetts.
March.
Notes: 
Due to the lack of health-based comparison values for surface water, results were compared to Massachusetts drinking water standards. When a 
Massachusetts drinking water standard was not available, results were compared to ATSDR drinking water comparison 
  
  
 
 
  
 
 
  
 
 
 
 
  
   
     
  
  
    
 
  Table 5: Carcinogenic Classifications of Active Ingredients of Pesticides Applied to Ginn Field, 2003 - 2004 
Pesticide 
Name 
Active Ingredient (% by Weight) CAS No. IARC
Classification 
USEPA Classification 
Confront Triclopyr Triethylamine (TEA) Salt (33%) 57213-69-1 Not classified 
Class D - Not Classifiable as to Human 
Carcinogenicity 
Herbicide 
Clopyralid Triethylamine (TEA) Salt (12.1%) 119308-91-7 Not classified 
Not Likely to be Carcinogenic to 
Humans 
Millennium 
Ultra 
Herbicide 
Dimethylamine Salt of 2,4-Dichlorophenoxyacetic
Acid (2,4-D) (37.32%) 
2008-39-1 Group 2B* 
Class D - Not Classifiable as to Human 
Carcinogenicity 
Monoethanolamine Salt of Clopyralid (3,6­
Dichloro-2-Pyridinecarboxylic Acid) (2.54%) 
57754-85-5 Not classified Not Likely to be Carcinogenic to 
Humans 
Dimethylene Salt of Dicamba (3,6-Dichloro-o­
anisic Acid) (4.65%) 
2300-66-5 Group 2B* 
Not Likely to be Carcinogenic to 
Humans 
Vanquish 
Herbicide 
Diglycolamine Salt of Dicamba (3,6-Dichloro-o­
anisic Acid) (56.8%) 
1040440-79-1 Group 2B* 
Not Likely to be Carcinogenic to 
Humans 
*The IARC lists chlorophenoxy herbicides as Group 2B carcinogens.
IARC Classification: 
Group 1 - The agent is carcinogenic to humans.
 
Group 2A - The agent is probably carcinogenic to humans.
 
Group 2B - The agent is possibly carcinogenic to humans.
 
Group 3 - The agent is not classifiable as to its carcinogenicity to humans.
 
Group 4 - The agent is probably not carcinogenic to humans.
 
Data Sources: 
Dow AgroSciences LLC. 2007. Material Safety Data Sheet: Confront Herbicide. July 5.
 
International Agency for Research on Cancer (IARC). 2009. Agents Reviewed by the IARC Monographs (Volumes 1-100A). April.
 
Nufarm Americas Inc. 2009. Material Safety Data Sheet: Vanquish Herbicide. July 1.
 
Nufarm Americas Inc. 2008. Material Safety Data Sheet: Millenium Ultra. May 14.
 
USEPA. 2009e. Office of Pesticide Programs List of Chemicals Evaluated for Carcinogenic Potential. September 3.
 
USEPA. 2005b. Dicamba: HED Chapter of the Reregistration Eligibility Decision Document (RED) – Phase 1. September 13.
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TABLE 6
 
Cancer Incidence
 
Winchester, Massachusetts
 
2000-2005
 
Cancer Type Total Males Females 
Obs Exp SIR 95% CI Obs Exp SIR 95% CI Obs Exp SIR 95% CI 
All Childhood Cancer 7 5.8 121 49  -- 250 6 3.1 195 71 -- 423 1 2.7 NC NC -­ NC 
Note: SIRs are calculated based on the exact number of expected diagnoses. 
Expected number of diagnoses presented are rounded to the nearest tenth. 
SIRs and 95% CIs are not calculated when the observed number is < 5. 
Obs = Observed number of diagnoses 95% CI = 95% Confidence Interval 
Exp = Expected number of diagnoses NC = Not calculated 
SIR = Standardized Incidence Ratio * = Statistical significance 
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health. 
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APPENDIX A: EXPOSURE DOSE AND CANCER RISK CALCULATIONS FOR 

EXPOSURE VIA INGESTION OF SURFACE SOIL 
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[C]  IR  NC_EFCF
NC_D  soil 
BW 
Cancer Effects Exposure Factor: 
FEDC_EF 
70 years365 days
Cancer Effects Exposure Dose: 
[C]  IR C_EFCF
C_D  soil 
     
 
    
   
 
 
 
    
 
 
 
 
 
 
concentration. 
3.	 The amount of soil ingested was assumed to be 100 milligrams per day for the adult receptor and 200 
 
 
 
 
milligrams per day for the child and adolescent receptors. 
4.	 The exposure factor was determined assuming the receptors were exposed to surface soil 5 days per 
week, for 22 weeks per year over a 30 year time period for an adult, a 6 year time period for an 
adolescent and an 11 year time period for a child.   
5.	 The average body weight was assumed to be as follows: adult = 70 kilograms; adolescent = 50 

kilograms; and child = 30 kilograms.
 
6.	 The cancer exposure dose for an adolescent was added to that of a child to represent the situation in 
which an adolescent was also exposed as a child. 
BW 
Cancer Risk: 
CR C_DCSF 
Where: 
NC_EF = Noncancer Exposure Factor (unitless) 

F  = Frequency of Exposure (days/year) 

ED  = Years of Exposure (years) 

NC_D = Noncancer Exposure Dose (mg/kg/day) 

   [C]soil = Maximum Analyte Concentration in Soil (mg/kg) 

IR  = Soil Ingestion Rate (mg/day) 

CF  = Conversion Factor (kg/mg) 

BW  = Body Weight (kg) 

C_EF  = Cancer Exposure Factor (unitless) 

C_D = Cancer Exposure Dose (mg/kg/day) 

CR  = Cancer Risk (unitless) 

CSF  = Cancer Slope Factor (mg/kg/day –1) 

Assumptions: 
1.	 The receptors evaluated were children (under age 12), adolescents (ages 12 to less than 18) and adults 
(age 18 and above). 
2.	 The maximum concentration of arsenic and lead detected in surface soil samples was assumed as the soil 
Exposure Dose and Cancer Risk Calculation Formulas: 
Noncancer Health Effects Exposure Factor: 
FEDNC_EF 
ED365 days
Noncancer Health Effects Exposure Dose: 
APPENDIX A 
 
Exposure Dose and Cancer Risk Calculations for Exposure via Ingestion of Surface Soil 

Ginn Field, Winchester, Massachusetts 
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               98 mg/kg100 mg/day  0.1310-6 kg/mgCancer Effects Exposure Dose   0.000018 mg/kg/day
110 days/year30 yearsNoncancer Health Effects Exposure Factor   0.30 
30 years365 days
98 mg/kg100 mg/day  0.310-6 kg/mgNoncancer Health Effects Exposure Dose   0.000042 mg/kg/day
70 kg 
110 days/year30 yearsCancer Effects Exposure Factor   0.13 
70 years365 days
Exposure Dose and Cancer Risk Calculations for Ingestion of Surface Soil Containing Arsenic: 
1. Adult (age 18 and over) 
 
      
 
 
     
       
 
   
 
            
 
     
       
70 kg 
Cancer Risk  0.0000181.5  0.000027 
2. Adolescent (ages 12 to less than 18) 
110 days/year 6 yearsNoncancer Health Effects Exposure Factor   0.30 
6 years365 days
98 mg/kg 200 mg/day  0.3010-6 kg/mgNoncancer Health Effects Exposure Dose   0.00012 mg/kg/day
50 kg 
110 days/year 6 yearsCancer Effects Exposure Factor   0.03 
70 years365 days
    
 
            
      
98 mg/kg 200 mg/day  0.0310-6 kg/mgCancer Effects Exposure Dose   0.00001 mg/kg/day
50 kg 
Cancer Risk  0.000011.5  0.000015 
 
 
     
       
 
   
 
            
3. Child (under age 12) 
110 days/year11 yearsNoncancer Health Effects Exposure Factor   0.30 
11 years365 days
98 mg/kg 200 mg/day  0.3010-6 kg/mgNoncancer Health Effects Exposure Dose   0.00020 mg/kg/day
30 kg 
 
APPENDIX A 
Exposure Dose and Cancer Risk Calculations for Exposure via Ingestion of Surface Soil 

Ginn Field, Winchester, Massachusetts 
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Exposure Dose and Cancer Risk Calculations for Exposure via Ingestion of Surface Soil 
Ginn Field, Winchester, Massachusetts 
110 days/year11 yearsCancer Effects Exposure Factor   0.05 
70 years365 days
98 mg/kg 200 mg/day  0.0510-6 kg/mgCancer Effects Exposure Dose   0.000031mg/kg/day
30 kg 
Cancer Risk  0.0000311.5  0.000046 
4. Adolescent and Child 
Cancer Risk = Cancer Risk of Child + Cancer Risk of Adolescent 
Cancer Risk = 0.000015 + 0.000046 = 0.000061 
 
 
NOTES: 
1. The ATSDR Chronic Oral MRL for arsenic is 0.0003 mg/kg/day. 
2. The USEPA Oral Cancer Slope Factor for arsenic is 1.5 mg/kg/day-1. 
APPENDIX A 
  
 
     
       
   
 
          
 
 
     
       
   
 
          
 
 
     
       
   
 
          
 
Exposure Dose and Cancer Risk Calculations for Exposure via Ingestion of Surface Soil 

Ginn Field, Winchester, Massachusetts 

Exposure Dose and Noncancer Risk Calculations for Ingestion of Surface Soil Containing Lead: 
1. Adult (age 18 and over) 
110 days/year30 yearsNoncancer Health Effects Exposure Factor 	  0.30 
30 years365 days
930 mg/kg100 mg/day  0.30 x 10-6 Noncancer Health Effects Exposure Dose 	  0.0004 mg/kg/day
70 kg 
2. Adolescent (ages 12 to less than 18) 
110 days/year 6 yearsNoncancer Health Effects Exposure Factor 	  0.30 
6 years365 days
930 mg/kg 200 mg/day  0.30 x 10-6 Noncancer Health Effects Exposure Dose 	  0.0011mg/kg/day
50 kg 
3. Child (under age 12) 
110 days/year11 yearsNoncancer Health Effects Exposure Factor 	  0.30 
11 years365 days
930 mg/kg 200 mg/day  0.30 x 10-6 Noncancer Health Effects Exposure Dose 	  0.0019 mg/kg/day
30 kg 
 60
 
  
APPENDIX A 
NOTES: 
1. 	 There is no ATSDR MRL or USEPA RfD available for lead. The calculated exposure dose for lead was 
input into the USEPA’s Integrated Exposure Uptake Biokinetic Model for Lead in Children (IEUBK) 
Windows® (IEUBKwin, Lead Model Version 1.1, Build 9) to estimate blood lead (PbB) levels in 
children exposed to lead-contaminated media.  The IEUBK model results indicated that exposure to the 
average concentration of lead detected in surface soil (298 mg/kg) would not result in a predicted mean 
blood lead concentration above 10 μg/dL, which the CDC defines as a level of concern. 
2. 	 The USEPA has categorized lead as a probable human carcinogen; however, they have concluded that 
existing scientific information cannot determine whether or not exposure to lead can cause cancer in 
humans; thus, no USEPA Oral Cancer Slope Factor has been developed for lead.  Due to the lack of 
evidence for cancer health effects in humans, cancer risk was not calculated for lead.  
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APPENDIX B: EXPOSURE DOSE AND CANCER RISK CALCULATIONS FOR 

EXPOSURE VIA DERMAL CONTACT WITH SURFACE SOIL
 
  
 
    
     
       
   
     
     
        
   
     
 
    
  
    
 
soil 
SAF  = Soil Adherence Factor (mg/cm2) 

SA = Exposed Body Surface Area (cm2) 

AF = Absorption Factor (Dermal) (unitless) 

    
 
C_D = Cancer Exposure Dose (mg/kg/day) 

CR  = Cancer Risk (unitless) 

–1

 
 
 
CSF  = Cancer Slope Factor (mg/kg/day ) 
Assumptions: 
1.	 The receptors evaluated were children (under age 12), adolescents (ages 12 to less than 18) and 
adults (age 18 and above). 
CF  = Conversion Factor (kg/mg) 

BW  = Body Weight (kg) 

C_EF  = Cancer Exposure Factor (unitless) 

Where: 
NC_EF = Noncancer Exposure Factor (unitless) 

F  = Frequency of Exposure (days/year) 

ED  = Years of Exposure (years) 

NC_D = Noncancer Exposure Dose (mg/kg/day) 

   [C] = Maximum Analyte Concentration in Surface Soil (mg/kg) 

 
 
 
  
 
2.	 The maximum concentration of arsenic and lead detected in surface soil samples was assumed as the 
soil concentration. 
3.	 The exposure factor was determined assuming the receptors were exposed to surface soil 5 days per 
week, for 22 weeks per year over a 30 year time period for an adult, a 6 year time period for an 
adolescent and an 11 year time period for a child.   
4.	 The average body weight was assumed to be as follows: adult = 70 kilograms; adolescent = 50 
kilograms; and child = 30 kilograms.
5.	 The cancer exposure dose for an adolescent was added to that of a child to represent the situation in 
which an adolescent was also exposed as a child. 
FEDC_EF 
70 years365 days
Cancer Effects Exposure Dose: 
[C] SAFSA AFCF C_EF
C_D  soil 
BW 
Cancer Risk: 
CR C_DCSF 
Exposure Dose and Cancer Risk Calculations for Exposure via Dermal Contact with Surface Soil 
Ginn Field, Winchester, Massachusetts 
Exposure Dose and Cancer Risk Calculation Formulas: 
Noncancer Health Effects Exposure Factor: 
FEDNC_EF 
ED365 days
Noncancer Health Effects Exposure Dose: 
[C]soil SAFSA  AFCF NC_EFNC_D 
BW 
Cancer Effects Exposure Factor: 
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2 2 -698 mg/kg  0.3 mg/cm 5700 cm  0.03 10 kg/mg  0.13Cancer Effects Exposure Dose   0.0000093 mg/kg/day
70 kg 
Cancer Risk  0.000000791.5  0.000014 
2. Adolescent (ages 12 to less than 18) 
110 days/year 6 yearsNoncancer Health Effects Exposure Factor   0.30 
6 years365 days
2 2 -698 mg/kg  0.3 mg/cm  4266cm  0.0310 kg/mg  0.30Noncancer Health Effects Exposure Dose   0.000023 mg/kg/day
50 kg 
 
     
       
 
   
 
              
 
      
 
 
     
       
 
   
 
             
 
       
110 days/year 6 yearsCancer Effects Exposure Factor   0.03 
70 years365 days
98 mg/kg  0.3 mg/cm2 4266 cm2 0.0310-6 kg/mg  0.03Cancer Effects Exposure Dose   0.000002 mg/kg/day
50 kg 
Cancer Risk  0.0000021.5  0.000003 
3. Child (under age 12) 
110 days/year11 yearsNoncancer Health Effects Exposure Factor   0.30 
11 years365 days
2 2 -698 mg/kg  0.2 mg/cm  2625cm  0.0310 kg/mg  0.30Noncancer Health Effects Exposure Dose   0.000016 mg/kg/day
30 kg 
110 days/year11 yearsCancer Effects Exposure Factor   0.05  
Exposure Dose and Cancer Risk Calculations for Exposure via Dermal Contact with Surface Soil 

Ginn Field, Winchester, Massachusetts 

Exposure Dose and Cancer Risk Calculations for Dermal Contact with Surface Soil Containing 

Arsenic: 

1. Adult (age 18 and above) 
110 days/year30 yearsNoncancer Health Effects Exposure Factor   0.30 
30 years365 days
2 2 -698 mg/kg  0.3 mg/cm  5700cm  0.03 10 kg/mg  0.30Noncancer Health Effects Exposure Dose   0.000022 mg/kg/
70 kg 
110 days/year30 yearsCancer Effects Exposure Factor   0.13 
70 years365 days
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day
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Exposure Dose and Cancer Risk Calculations for Exposure via Dermal Contact with Surface Soil 

Ginn Field, Winchester, Massachusetts 

98 mg/kg0.2mg/cm2 2625cm20.0310-6 kg/mg  0.05Cancer Effects Exposure Dose   0.0000024 mg/kg/day
30 kg 
Cancer Risk  0.00000241.5  0.0000037 
4. Adolescent and Child 
Cancer Risk = Cancer Risk of Child + Cancer Risk of Adolescent 
Cancer Risk = 0.000003 + 0.0000037 = 0.000067 
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NOTES: 
1. The ATSDR Chronic MRL for arsenic is 0.0003 mg/kg/day.  
2. The USEPA Oral Cancer Slope Factor for arsenic is 1.5 mg/kg/day-1. 
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APPENDIX C: EXPOSURE DOSE AND CANCER RISK CALCULATIONS FOR 

EXPOSURE VIA INGESTION OF SEDIMENT 

  
 
    
     
      
   
     
     
      
   
     
 
    
   
    
 
 
    
NC_EF = Noncancer Exposure Factor (unitless) 

F  = Frequency of Exposure (days/year) 

ED  = Years of Exposure (years) 

NC_D = Noncancer Exposure Dose (mg/kg/day) 

   [C]soil = Maximum Analyte Concentration in Sediment (mg/kg) 

IR = Sediment Ingestion Rate (mg/day) 

CF  = Conversion Factor (kg/mg) 

BW  = Body Weight (kg) 

C_EF  = Cancer Exposure Factor (unitless) 

C_D = Cancer Exposure Dose (mg/kg/day) 

 CR  = Cancer Risk (unitless) 

–1
Where: 
 
 
 
 
 
 
 
    
 
CSF  = Cancer Slope Factor (mg/kg/day ) 

Assumptions: 
1.	 The receptors evaluated were children (under age 12), adolescents (ages 12 to less than 18) and 
adults (age 18 and above). 
2.	 The maximum concentration of benzo(a)pyrene detected in sediment samples was assumed as the 
sediment concentration. 
3.	 The amount of sediment ingested was assumed to be 100 milligrams per day for the adult receptor 
and 200 milligrams per day for the child and adolescent receptors. 
4.	 The exposure factor was determined assuming the receptors were exposed to sediment 5 days per 
week, for 22 weeks per year over a 30 year time period for an adult, a 6 year time period for an 
adolescent and an 11 year time period for a child.   
5.	 The average body weight was assumed to be as follows: adult = 70 kilograms; adolescent = 50 
kilograms; and child = 30 kilograms.
6.	 The cancer exposure dose for an adolescent was added to that of a child to represent the situation in 
which an adolescent was also exposed as a child. 
Exposure Dose and Cancer Risk Calculations for Exposure via Ingestion of Sediment 

Ginn Field, Winchester, Massachusetts 

Exposure Dose and Cancer Risk Calculation Formulas: 
Noncancer Health Effects Exposure Factor: 
FEDNC_EF 
ED365 days
Noncancer Health Effects Exposure Dose: 
[C]  IR  NC_EFCF
NC_D  soil 
BW 
Cancer Effects Exposure Factor: 
FEDC_EF 
70 years365 days
Cancer Effects Exposure Dose: 
[C]  IR C_EFCF
C_D  soil 
BW 
Cancer Risk: 
CR C_DCSF 
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Adolescent (ages 12 to less than 18) 
110 days/year 6 yearsNoncancer Health Effects Exposure Factor   0.30 
6 years365 days
3.5 mg/kg 200 mg/day  0.3010-6 kg/mgoncancer Health Effects Exposure Dose   0.0000042 mg/kg/day
50 kg 
 
     
       
   
 
            
      
 
 
     
       
 
   
 
            
 
110 days/year 6 yearsCancer Effects Exposure Factor   0.03 
70 years365 days
3.5 mg/kg 200 mg/day  0.0310-6 kg/mgCancer Effects Exposure Dose   0.0000004 mg/kg/day
50 kg 
Cancer Risk  0.0000004 7.3 0.000003 
Child (under age 12) 
110 days/year11 yearsNoncancer Health Effects Exposure Factor   0.30 
11 years365 days
3.5 mg/kg 200 mg/day  0.3010-6 kg/mgoncancer Health Effects Exposure Dose   0.000007 mg/kg/day
30 kg 
Exposure Dose and Cancer Risk Calculations for Exposure via Ingestion of Sediment 

Ginn Field, Winchester, Massachusetts 

Exposure Dose and Cancer Risk Calculations for Ingestion of Sediment Containing Benzo(a)pyrene: 
1. Adult (age 18 and over) 
110 days/year30 yearsNoncancer Health Effects Exposure Factor   0.30 
30 years365 days
3.5 mg/kg100 mg/day  0.3010-6 kg/mgNoncancer Health Effects Exposure Dose   0.0000015 mg/kg/day
70 kg 
110 days/year30 yearsCancer Effects Exposure Factor   0.13 
70 years365 days
3.5 mg/kg100 mg/day  0.1310-6 kg/mgCancer Effects Exposure Dose   0.00000065 mg/kg/day
70 kg 
Cancer Risk  0.00000065 7.3 0.0000047 
2.
N
APPENDIX C 
3.
N
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NOTES: 
1. 	 The USEPA RfD for pyrene (0.03 mg/kg/day) was used to evaluate noncancer health effects from
exposure to benzo(a)pyrene. 
2. 	 The USEPA Oral Cancer Slope Factor for benzo(a)pyrene is 7.3 mg/kg/day-1. 
APPENDIX C 
Exposure Dose and Cancer Risk Calculations for Exposure via Ingestion of Sediment 
Ginn Field, Winchester, Massachusetts 
110 days/year11 yearsCancer Effects Exposure Factor 	  0.05 
70 years365 days
3.5 mg/kg 200 mg/day  0.0510-6 kg/mgCancer Effects Exposure Dose 	  0.000001mg/kg/day
30 kg 
Cancer Risk  0.000001 7.3 0.000007 
4. Adolescent and Child 
Cancer Risk = Cancer Risk of Child + Cancer Risk of Adolescent 
Cancer Risk = 0.000003 + 0.000007 = 0.00001 
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 AF = Absorption Factor (Dermal) (unitless) 

CF  = Conversion Factor (kg/mg) 

BW  = Body Weight (kg) 

C_EF  = Cancer Exposure Factor (unitless) 

   
 
 
 
 
 
 
    
 
week, for 22 weeks per year over a 30 year time period for an adult, a 6 year time period for an 
adolescent and an 11 year time period for a child.   
4.	 The average body weight was assumed to be as follows: adult = 70 kilograms; adolescent = 50 
kilograms; and child = 30 kilograms.
5.	 The cancer exposure dose for an adolescent was added to that of a child to represent the situation in 
which an adolescent was also exposed as a child. 
C_D = Cancer Exposure Dose (mg/kg/day) 

CR  = Cancer Risk (unitless) 

CSF  = Cancer Slope Factor (mg/kg/day –1) 

Assumptions: 
1.	 The receptors evaluated were children (under age 12), adolescents (ages 12 to less than 18) and 
adults (age 18 and above). 
2.	 The maximum concentration of benzo(a)pyrene detected in sediment samples was assumed as the 
sediment concentration. 
3.	 The exposure factor was determined assuming the receptors were exposed to sediment 5 days per 
Exposure Dose and Cancer Risk Calculations for Exposure via Dermal Contact with Sediment 

Ginn Field, Winchester, Massachusetts 

Exposure Dose and Cancer Risk Calculation Formulas: 
Noncancer Health Effects Exposure Factor: 
FEDNC_EF 
ED365 days
Noncancer Health Effects Exposure Dose: 
[C] SAFSA  AFCF NC_EF
NC_D  soil 
BW 
Cancer Effects Exposure Factor: 
FEDC_EF 
70 years365 days
Cancer Effects Exposure Dose: 
[C] SAFSA AFCF C_EF
C_D  soil 
BW 
Cancer Risk: 
CR C_DCSF 
Where: 
NC_EF = Noncancer Exposure Factor (unitless) 

F  = Frequency of Exposure (days/year) 

ED  = Years of Exposure (years) 

NC_D = Noncancer Exposure Dose (mg/kg/day) 

   [C]soil = Maximum Analyte Concentration in Sediment (mg/kg) 

SAF  = Soil Adherence Factor (mg/cm2) 

SA = Exposed Body Surface Area (cm2) 
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APPENDIX D 
Exposure Dose and Cancer Risk Calculations for Exposure via Dermal Contact with Sediment 

Ginn Field, Winchester, Massachusetts 

Exposure Dose and Cancer Risk Calculations for Dermal Contact with Sediment Containing 
Benzo(a)pyrene: 
1. Adult (age 18 and over) 
110 days/year30 yearsNoncancer Health Effects Exposure Factor   0.30 
30 years365 days
2 2 -63.5 mg/kg  0.3 mg/cm  5700cm  0.13 10 kg/mg  0.30Noncancer Health Effects Exposure Dose   0.0000033 mg/kg/day
70 kg 
110 days/year30 yearsCancer Effects Exposure Factor   0.13 
70 years365 days
2 2 -63.5 mg/kg  0.3 mg/cm 5700 cm  0.13 10 kg/mg  0.13Cancer Effects Exposure Dose   0.0000014 mg/kg/day
70 kg 
Cancer Risk  0.0000014 7.3 0.00001 
2. Adolescent (ages 12 to less than 18) 
110 days/year 6 yearsNoncancer Health Effects Exposure Factor   0.30 
6 years365 days
2 2 -63.5 mg/kg  0.3 mg/cm  4266cm  0.1310 kg/mg  0.30Noncancer Health Effects Exposure Dose   0.0000035 mg/kg/day
50 kg 
110 days/year 6 yearsCancer Effects Exposure Factor   0.03 
70 years365 days
3.5 mg/kg  0.3 mg/cm2 4266 cm2 0.1310-6 kg/mg  0.03Cancer Effects Exposure Dose   0.0000003 mg/kg/day
50 kg 
Cancer Risk  0.0000003 7.3 0.000002 
3. Child (under age 12) 
110 days/year11 yearsNoncancer Health Effects Exposure Factor   0.30 
11 years365 days
2 2 -63.5 mg/kg  0.2 mg/cm  2625cm  0.1310 kg/mg  0.30Noncancer Health Effects Exposure Dose   0.0000024 mg/kg/day
30 kg 
110 days/year11 yearsCancer Effects Exposure Factor   0.05 
70 years365 days
  
 
   
 
                
 
      
 
 
 
 
Exposure Dose and Cancer Risk Calculations for Exposure via Dermal Contact with Sediment 

Ginn Field, Winchester, Massachusetts 

3.5 mg/kg 0.2 mg/cm2 2625 cm2 0.1310-6 kg/mg  0.05Cancer Effects Exposure Dose 	  0.0000004 mg/kg/day
30 kg 
Cancer Risk  0.0000004 7.3 0.000003 
4. Adolescent and Child 
Cancer Risk = Cancer Risk of Child + Cancer Risk of Adolescent 
Cancer Risk = 0.000002 + 0.000003 = 0.000005 
 72
 
 
 
 
 
   
NOTES: 
1. 	 The USEPA RfD for pyrene (0.03 mg/kg/day) was used to evaluate noncancer health effects from
exposure to benzo(a)pyrene. 
2. 	 The USEPA Oral Cancer Slope Factor for benzo(a)pyrene is 7.3 mg/kg/day-1. 
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Exposure Dose and Cancer Risk Calculations for Exposure via Ingestion of Surface Water During Base 
Flow Conditions 

Ginn Field, Winchester, Massachusetts 

Exposure Dose and Cancer Risk Calculation Formulas: 
Noncancer Health Effects Exposure Factor: 
FEDNC_EF 
ED365 days
Noncancer Health Effects Exposure Dose: 
[C]  IR  NC_EFsurface waterNC_D 
BW 
Where: 
NC_EF = Noncancer Exposure Factor (unitless) 

F  = Frequency of Exposure (days/year) 

ED  = Years of Exposure (years) 

NC_D = Noncancer Exposure Dose (mg/kg/day) 

   [C]surface water = Maximum Analyte Concentration in Surface Water (mg/L) 

IR = Surface Water Ingestion Rate (L/day) 

BW  = Body Weight (kg) 

Assumptions: 
1.	 The receptors evaluated were children (under age 12), adolescents (ages 12 to less than 18) and adults 
(age 18 and above). 
2.	 The maximum concentration of thallium detected in surface water during base flow conditions was 
assumed as the surface water concentration.  
3.	 The amount of surface water ingested was assumed to be 0.05 liters per day.  
4.	 The exposure factor was determined assuming the receptors were exposed to surface water 5 days per 
week, for 22 weeks per year over a 30 year time period for an adult, a 6 year time period for an 
adolescent and an 11 year time period for a child.   
5.	 The average body weight was assumed to be as follows: adult = 70 kilograms; adolescent = 50 
kilograms; and child = 30 kilograms.
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Exposure Dose and Cancer Risk Calculations for Exposure via Ingestion of Surface Water During Base 
Flow Conditions 

Ginn Field, Winchester, Massachusetts 

Exposure Dose and Cancer Risk Calculations for Ingestion of Surface Water Containing Thallium: 
1. Adult (age 18 and over) 
110 days/year30 yearsNoncancer Health Effects Exposure Factor 	  0.30 
30 years365 days
0.0052 mg/L 0.05 L/day  0.30Noncancer Health Effects Exposure Dose 	  0.0000011mg/kg/day
70 kg 
2. Adolescent (ages 12 to less than 18) 
110 days/year 6 yearsNoncancer Health Effects Exposure Factor 	  0.30 
6 years365 days
0.0052 mg/L 0.05 L/day 0.30Noncancer Health Effects Exposure Dose 	  0.0000016 mg/kg/day
50 kg 
3. Child (under age 12) 
110 days/year11 yearsNoncancer Health Effects Exposure Factor 	  0.30 
11 years365 days
0.0052 mg/L 0.05 L/day 0.30Noncancer Health Effects Exposure Dose 	  0.0000026 mg/kg/day
30 kg 
 
 
 
NOTES: 
1. 	 The USEPA RfD for thallium sulfate (0.0008 mg/kg/day) was used to evaluate noncancer health effects 
from thallium detected in Reach 5. 
2. 	 The USEPA has not classified thallium with respect to its cancer causing potential and has not 
developed a USEPA Oral Cancer Slope Factor for thallium.  Due to the lack of evidence for cancer 
health effects in humans, cancer risk was not calculated for thallium.   
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APPENDIX F: EXPOSURE DOSE AND CANCER RISK CALCULATIONS FOR 

EXPOSURE VIA INGESTION OF SURFACE WATER DURING STORM FLOW 

CONDITIONS
 
  
    
     
    
   
     
     
   
   
     
 
    
  
    
    
 
 
 
 
CSF  = Cancer Slope Factor (mg/kg/day –1) 

Assumptions: 
1.	 The receptors evaluated were children (under age 12), adolescents (ages 12 to less than 18) and adults 
 
 
 
 
    
 
3.	 The amount of surface water ingested was assumed to be 0.05 liters per day.  
4.	 The exposure factor was determined assuming the receptors were exposed to surface water 1 day per 
week, for 22 weeks per year over a 30 year time period for an adult, a 6 year time period for an 
adolescent and an 11 year time period for a child.   
5.	 The average body weight was assumed to be as follows: adult = 70 kilograms; adolescent = 50 
kilograms; and child = 30 kilograms.
6.	 The cancer exposure dose for an adolescent was added to that of a child to represent the situation in 
which an adolescent was also exposed as a child. 
(age 18 and above). 
2.	 The maximum contaminant concentration detected in surface water during storm flow conditions was 
assumed as the surface water concentration.  
Exposure Dose and Cancer Risk Calculations for Exposure via Ingestion of Surface Water During Storm 
Flow Conditions 
Ginn Field, Winchester, Massachusetts 
Exposure Dose and Cancer Risk Calculation Formulas: 
Noncancer Health Effects Exposure Factor: 
FEDNC_EF 
ED365 days
Noncancer Health Effects Exposure Dose: 
[C]  IR  NC_EFsurface waterNC_D 
BW 
Cancer Effects Exposure Factor: 
FEDC_EF 
70 years365 days
Cancer Effects Exposure Dose: 
[C]  IR  C_EFsurface waterC_D 
BW 
Cancer Risk: 
CR C_DCSF 
Where: 
NC_EF = Noncancer Exposure Factor (unitless) 

F  = Frequency of Exposure (days/year) 

ED  = Years of Exposure (years) 

NC_D = Noncancer Exposure Dose (mg/kg/day) 

   [C]surface water = Maximum Analyte Concentration in Surface Water (mg/L) 

IR = Surface Water Ingestion Rate (L/day) 

BW  = Body Weight (kg) 

C_EF  = Cancer Exposure Factor (unitless) 

C_D = Cancer Exposure Dose (mg/kg/day) 

CR  = Cancer Risk (unitless) 
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APPENDIX F 

Exposure Dose and Cancer Risk Calculations for Exposure via Ingestion of Surface Water During Storm 
Flow Conditions 

Ginn Field, Winchester, Massachusetts 

Exposure Dose and Cancer Risk Calculations for Ingestion of Surface Water Containing Arsenic: 
1. Adult (age 18 and over) 
22 days/year30 yearsNoncancer Health Effects Exposure Factor   0.06 
30 years365 days
0.427 mg/L 0.05 L/day 0.06Noncancer Health Effects Exposure Dose   0.000018 mg/kg/day
70 kg 
22 days/year30 yearsCancer Effects Exposure Factor   0.026 
70 years365 days
0.427 mg/kg  0.05 L/day  0.026Cancer Effects Exposure Dose   0.0000079 mg/kg/day
70 kg 
Cancer Risk  0.00000791.5  0.000012 
2. Adolescent (ages 12 to less than 18) 
22 days/year 6 yearsNoncancer Health Effects Exposure Factor   0.06 
6 years365 days
0.427 mg/L 0.05 L/day 0.06Noncancer Health Effects Exposure Dose   0.000026 mg/kg/day
50 kg 
22 days/year 6 yearsCancer Effects Exposure Factor   0.005 
70 years365 days
0.427 mg/kg  0.05 L/day  0.005Cancer Effects Exposure Dose   0.0000021 mg/kg/day
50 kg 
Cancer Risk  0.00000211.5  0.0000032 
3. Child (under age 12) 
22 days/year11 yearsNoncancer Health Effects Exposure Factor   0.06 
11 years365 days
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NOTES: 
1. 	 The ATSDR Chronic Oral MRL for arsenic is 0.0003 mg/kg/day. 
2. 	 The USEPA Oral Cancer Slope Factor for arsenic is 1.5 mg/kg/day-1. 
3. 	 The calculations shown above for arsenic are provided as an example of those for the other constituents 
that had levels detected in at least one surface water sample that exceeded drinking water comparison 
values (aluminum, cadmium, chromium, copper, iron, lead, manganese, mercury, sodium, vanadium and 
zinc). 
APPENDIX F 

Exposure Dose and Cancer Risk Calculations for Exposure via Ingestion of Surface Water During Storm 
Flow Conditions 

Ginn Field, Winchester, Massachusetts 

0.427 mg/L 0.05 L/day 0.06Noncancer Health Effects Exposure Dose 	  0.000043 mg/kg/day
30 kg 
22 days/year11 yearsCancer Effects Exposure Factor 	  0.009 
70 years365 days
0.427 mg/kg  0.05 L/day  0.009Cancer Effects Exposure Dose 	  0.0000064 mg/kg/day
30 kg 
Cancer Risk  0.00000641.5  0.000010 
4. Adolescent and Child 
Cancer Risk = Cancer Risk of Child + Cancer Risk of Adolescent 
Cancer Risk = 0.0000032 + 0.000010 = 0.000013 
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 I. Leukemias, myeloproliferative diseases, 
 and myelodysplastic diseases
  
  
 
 
   
 
 
   
    
  
   
    
   
 
  
 
  
    
   
   
   
   
  
   
 
 
 
 
 
  
  
                                                          
  
   
  
Appendix G 

Coding Definitions of Childhood Cancer 

ICD-O-3** codes 
ICCC Diagnostic Group Morphology Topography 
a. Lymphoid leukemias 9820, 9823, 9826, 9827, 9831-9837, 9940, 
9948
b. Acute myeloid leukemias 9840, 9861, 9866, 9867, 9870-9874, 9891, 
9895-9897, 9910, 9920, 9931 
c. Chronic myeloproliferative diseases 9863, 9875, 9876, 9950, 9960-9964
d. Myelodysplastic syndrome and other 9945, 9946, 9975, 9980, 9982-9987, 9989
myeloproliferative diseases 
e. Unspecified and other specified 9800, 9801, 9805, 9860, 9930 
leukemias 
II.  Lymphomas and reticuloendothelial
neoplasms 
a. Hodgkin Lymphomas 9650-9655, 9659, 9661-9665, 9667
b. Non-Hodgkin lymphomas (except 9591, 9670, 9671, 9673, 9675, 9678-9680, 
Burkitt lymphoma) 9684, 9689-9691, 9695, 9698-9702, 9705, 
9708, 9709, 9714, 9716-9719, 9727-9729, 
9731-9734, 9760-9762, 9764-9769, 9970
 c. Burkitt lymphomas 9687
 d. Miscellaneous lymphoreticular 9740-9742, 9750, 9754-9758 
neoplasms 
e. Unspecified lymphomas 9590, 9596
III. Central nervous system and miscellaneous
intracranial and intraspinal neoplasms 
a. Ependymomas and choroid plexus 9383, 9390-9394a 
tumors 
b. Astrocytomas 9380a C72.3
9384, 9400-9411, 9420, 9421-9424, 9440­
9442a 
c. Intracranial and intraspinal embryonal 9470-9474, 9480, 9508a 
tumors 
 9501-9504a C70.0-C72.9
 d. Other gliomas 9380a C70.0-C72.2, C72.4-C72.9,
C75.1, C75.3
9381, 9382, 9430, 9444, 9450, 9451, 9460a 
e. Other specified intracranial and 8270-8281, 8300, 9350-9352, 9360-9362, 
intraspinal neoplasms 9412, 9413, 9492, 9493, 9505-9507, 9530­
9539, 9582a 
* Chart from: Steliarova-Foucher E, Stiller C, Lacour B and Kaatsch P. 2005. International Classification 
of Childhood Cancer, Third edition. Cancer, 103, 1457-1467. 
**International Classification of Diseases for Oncology, 3rd Ed.
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Appendix G 

Coding Definitions of Childhood Cancer 

f. Unspecified intracranial and Intraspinal 
neoplasms 8000-8005a C70.0-C72.9, C75.1-C75.3
IV. Neuroblastoma and other peripheral
nervous cell tumors 
a. Neuroblastoma and 
ganglioneuroblastoma
9490, 9500
b. Other peripheral nervous cell tumors 8680-8683, 8690-8693, 8700, 9520-9523
 9501-9504 C00.0-C69.9, C73.9-C76.8,
C80.9
V. Retinoblastoma 9510-9514  
VI. Renal Tumors
a. Nephroblastoma and other nonepithelial
renal tumors 
8959, 8960, 8964-8967
 8963, 9364 C64.9
b. Renal carcinoma 8010-8041, 8050-8075, 8082, 8120-8122, 
8130-8141, 8143, 8155, 8190-8201, 8210, 
8211, 8221-8231, 8240, 8241, 8244-8246, 
8260-8263, 8290, 8310, 8320, 8323, 8401, 
8430, 8440, 8480-8490, 8504, 8510, 8550, 
8560-8576 
C64.9
8311, 8312, 8316-8319, 8361 
c. Unspecified malignant renal tumors 8000-8005 C64.9 
VII. Hepatic Tumors 
a. Hepatoblastoma 8970
b. Hepatic carcinoma 8010-8041, 8050-8075, 8082, 8120-8122, 
8140, 8141, 8143, 8155, 8190-8201, 8210, 
8211, 8230, 8231, 8240, 8241, 8244-8246, 
8260-8264, 8310, 8320, 8323, 8401, 8430, 
8440, 8480-8490, 8504, 8510, 8550, 8560­
8576
C22.0, C22.1
 8160-8180 
c. Unspecified malignant hepatic tumors 8000-8005 C22.0, C22.1 
VIII. Malignant bone tumors
a. Osteosarcomas 9180-9187, 9191-9195, 9200 C40.0-C41.9, C76.0-C76.8,
C80.9
b. Chondrosarcomas 9210, 9220, 9240 C40.0-41.9, 76.0-76.8, 80.9
 9221, 9230, 9241-9243
c. Ewing tumor and related sarcomas of
bone 
9260 C40.0-C41.9, C76.0-76.8, 
C80.9
 9363-9365 C40.0-C41.9 
d. Other specified malignant bone tumors 8810, 8811, 8823, 8830 C40.0-C41.9
8812, 9250, 9261, 9270-9275, 9280-9282, 
9290, 9300-9302, 9310-9312, 9320-9322, 
9330, 9340-9342, 9370-9372 
C40.0-C41.9
e. Unspecified malignant bone tumors 8000-8005, 8800, 8801, 8803-8805 C40.0-C41.9
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IX.  Soft tissue and other extraosseous
sarcomas
a.  Rhabdomyosarcomas 8900-8905, 8910, 8912, 8920, 8991
b. Fibrosarcomas, peripheral nerve sheath
tumors, and other fibrous neoplasms 
8810, 8811, 8813-8815, 8821, 8823, 8834­
8835
C00.0-C39.9, C44.0-76.8, 
C80.9
c.  Kaposi sarcoma 9140
d.  Other specified soft tissue sarcomas 8587, 8710-8713, 8806, 8831-8833, 8836, 
8840-8842, 8850-8858, 8860-8862, 8870, 
8880, 8881, 8890-8898, 8921, 8982, 8990, 
9040-9044, 9120-9125, 9130-9133, 9135, 
9136, 9141, 9142, 9161, 9170-9175, 9231, 
9251, 9252, 9373, 9581
 8830 C00.0-C39.9, C44.0-C76.8,
C80.9
 8963 C00.0-C63.9, C65.9-C69.9,
C73.9-C76.8, C80.9
9180, 9210, 9220, 9240 C49.0-C49.9
 9260 C00.0-C39.9, C47.0-C75.9
 9364 C00.0-C39.9, C47.0-C63.9,
C65.9-C69.9, C73.9-C76.8,
C80.9
 9365 C00.0-C39.9, C47.0-C63.9,
C65.9-C76.8, C80.9
   e. Unspecified soft tissue sarcomas 8800-8805 C00.0-C39.9, C44.0-C76.8 
X.   Germ cell tumors, trophoblastic tumors,
and neoplasms of gonads 
a.  Intracranial and Intraspinal germ cell
tumors 
9060-9065, 9070-9072, 9080-9085, 9100, 
9101a 
C70.0-C72.9, C75.1-C75.3
b.   Malignant extracranial and extragonadal 
germ cell tumor
9060-9065, 9070-9072, 9080-9085, 9100­
9105
C00.0-C55.9, C57.0-C61.9,
C63.0-C69.9, C73.9-C75.0,
C75.4-C76.8, C80.9
 c.   Malignant gonadal germ cell tumors 9060-9065, 9070-9073, 9080-9085, 9090, 
9091, 9100, 9101
C56.9, C62.0-C62.9
 d.  Gonadal carcinomas 8010-8041, 8050-8075, 8082, 8120-8122, 
8130-8141, 8143, 8190-8201, 8210, 8211, 
8221-8241, 8244-8246, 8260-8263, 8290, 
8310, 8313, 8320, 8323, 8380-8384, 8430, 
8440, 8480-8490, 8504, 8510, 8550, 8560­
8573, 9000, 9014, 9015
C56.9, C62.0-C62.9
8441-8447, 8450, 8451, 8460-8473
e. Other and unspecified malignant gonadal 
tumors 
8590-8671  
 8000-8005 C56.9, C62.0-C62.9
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XI. Other malignant epithelial neoplasms and
malignant melanomas 
a. Adrenocortical carcinomas 8370-8375 
b. Thyroid carcinomas 8010-8041, 8050-8075, 8082, 8120-8122, 
8130-8141, 8190, 8200, 8201, 8211, 8230, 
8231, 8244-8246, 8260-8263, 8290, 8310, 
8320, 8323, 8430, 8440, 8480, 8481, 8510, 
8560-8573 
C73.9
 8330-8337, 8340-8347, 8350 
c. Nasopharyngeal carcinomas 8010-8041, 8050-8075, 8082, 8083, 8120­
8122, 8130-8141, 8190, 8200, 8201, 8211, 
8230, 8231, 8244-8246, 8260-8263, 8290, 
8310, 8320, 8323, 8430, 8440, 8480, 8481, 
8500-8576 
C11.0-C11.9
d. Malignant melanomas 8720-8780, 8790 
e. Skin carcinomas 8010-8041, 8050-8075, 8078, 8082, 8090­
8110, 8140, 8143, 8147, 8190, 8200, 8240, 
8246, 8247, 8260, 8310, 8320, 8323, 8390­
8420, 8430, 8480, 8542, 8560, 8570-8573, 
8940, 8941
C44.0-C44.9
f. Other and unspecified carcinomas 8010-8084, 8120-8157, 8190-8264, 8290, 
8310, 8313-8315, 8320-8325, 8360, 8380­
8384, 8430-8440, 8452-8454, 8480-8586, 
8588-8589, 8940, 8941, 8983, 9000, 9010­
9016, 9020, 9030
C00.0-C10.9, C12.9-C21.8,
C23.9-C39.9, C48.0-C48.8,
C50.0-C55.9, C57.0-C61.9,
C63.0-C63.9, C65.9-C72.9,
C75.0-C76.8, C80.9
XII.Other and unspecified malignant 
neoplasms 
a. Other specified malignant tumors 8930-8936, 8950, 8951, 8971-8981, 9050­
9055, 9110
 9363 C00.0-C39.9, C47.0-C75.9
b. Other unspecified malignant tumors 8000-8005 C00.0-C21.8, C23.9-C39.9,
C42.0-C55.9, C57.0-C61.9,
C63.0-C63.9, C65.9-C69.9,
C73.9-C75.0, C75.4-C80.9
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Explanation of a Standardized Incidence Ratio (SIR) 

And 95% Confidence Interval 

To determine whether an elevation is occurring among individuals diagnosed with cancer in a 
community or census tract (CT), cancer incidence data are tabulated by gender according to 
eighteen age groups to compare the observed number of cancer diagnoses to the number that
would be expected based on the statewide cancer rate. 
Specifically, an SIR is the ratio of the observed number of cancer diagnoses in an area to the 
expected number of diagnoses multiplied by 100.  Age-specific statewide incidence rates are 
applied to the population distribution of a community to calculate the number of expected cancer 
diagnoses. The SIR is a comparison of the number of diagnoses in the specific area (i.e., 
community or census tract) to the number of expected diagnoses based on the statewide rate.
Comparison of SIRs between communities or census tracts is not possible because each of these
areas has different population characteristics.   
To calculate an SIR, it is necessary to obtain accurate population information.  Population is 
interpolated based on U.S. census data for the community of interest.  Midpoint population 
estimates are calculated for each time period evaluated.  To estimate the population between
census years, an assumption is made that the change in population occurs at a constant rate
throughout the ten-year interval between each census. 
A CT is a geographic subdivision of a city or town designated by the United States Census
Bureau. Because age group and gender-specific population information is necessary to calculate 
incidence rates, the CT is the smallest geographic area for which cancer rates can be accurately 
calculated. Specifically, a CT is a smaller statistical subdivision of a county as defined by the 
U.S. Census Bureau. CTs usually contain between 1,500 and 8,000 persons and are designed to 
be homogenous with respect to population characteristics (U.S. DOC 2000).
An SIR of 100 indicates that the number of cancer diagnoses observed in the population 
evaluated is equal to the number of cancer diagnoses expected in the comparison or “normal” 
population.  An SIR greater than 100 indicates that more cancer diagnoses occurred than expected
and an SIR less than 100 indicates that fewer cancer diagnoses occurred than expected. 
Accordingly, an SIR of 150 is interpreted as 50% more diagnoses than the expected number; an 
SIR of 90 indicates 10% fewer diagnoses than expected.   
Caution should be exercised, however, when interpreting an SIR.  The interpretation of an SIR 
depends on both the size and the stability of the SIR.  Two SIRs can have the same size but not 
the same stability.  For example, an SIR of 150 based on four expected diagnoses and six 
observed diagnoses indicates a 50% excess in cancer, but the excess is actually only two 
diagnoses. Conversely, an SIR of 150 based on 400 expected diagnoses and 600 observed
diagnoses represents the same 50% excess in cancer, but because the SIR is based upon a greater
number of diagnoses, the estimate is more stable.  It is very unlikely that 200 excess diagnoses of
cancer would occur by chance alone.  As a result of the instability of incidence rates based on 
small numbers of diagnoses, SIRs are not calculated when fewer than five diagnoses are observed
for a particular cancer type.    
To help interpret or measure the stability of an SIR, the statistical significance of an SIR can be 
assessed by calculating a 95% confidence interval (95% CI) to determine if the observed number 
of diagnoses is “statistically significantly different” from the expected number or if the difference 
may be due solely to chance (Rothman and Boice 1982).  Specifically, a 95% CI is the range of 
estimated SIR values that has a 95% probability of including the true SIR for the population.  If 
the 95% CI range does not include the value 100, then the study population is significantly
different from the comparison or “normal” population.  “Significantly different” means there is 
Source: Community Assessment Program, Bureau of Environmental Health, Massachusetts Department of Public Health.
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less than 5% percent chance that the observed difference (either increase or decrease) in the rate
is the result of random fluctuation in the number of observed cancer diagnoses.   
For example, if a confidence interval does not include 100 and the interval is above 100 (e.g., 
105-130), then there is a statistically significant excess in the number of cancer diagnoses.
Similarly, if the confidence interval does not include 100 and the interval is below 100 (e.g., 45­
96), then the number of cancer diagnoses is statistically significantly lower than expected.  If the 
confidence interval range includes 100, then the true SIR may be 100.  In this case, it cannot be 
determined with certainty that the difference between the observed and expected number of 
diagnoses reflects a real cancer increase or decrease or is the result of chance.  It is important to 
note that statistical significance alone does not necessarily imply public health significance. 
Determination of statistical significance is just one tool used to interpret cancer patterns in a
community. 
In addition to the range of the estimates contained in the confidence interval, the width of the
confidence interval also reflects the stability of the SIR estimate.  For example, a narrow 
confidence interval, such as 103-115, allows a fair level of certainty that the calculated SIR is 
close to the true SIR for the population.  A wide interval, for instance 85-450, leaves considerable 
doubt about the true SIR, which could be much lower than or much higher than the calculated 
SIR. This would indicate an unstable statistic.  Again, due to the instability of incidence rates 
based on small numbers of diagnoses, statistical significance is not assessed when fewer than five 
diagnoses are observed.   
Source: Community Assessment Program, Bureau of Environmental Health, Massachusetts Department of Public Health.
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